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PHOPSPHORYLATION AND UBIQUITIN MODIFICATION
AT DNA DAMAGE SITES IN RESPONSE TO DOUBLE-STRAND BREAKS
Atanu Paul, M.S
Advisory Professor: Bin Wang, Ph.D.

Genomes of all organisms are continuously damaged by numerous
exogenous and endogenous sources leading to different kinds of DNA lesions,
which if not repaired efficiently may trigger wide-scale genomic instability, a hallmark
of cancer development. To overcome this, cells have evolved a sophisticated
sensory network called the DNA damage response (DDR) comprised of a large
number of distinct protein complexes categorized as sensor, mediator, transducer
and effector proteins that amplify the DNA damage signal and activate cell cycle
checkpoint to initiate DNA repair or trigger apoptosis where the defect is beyond
repair. This intricate signaling pathway is tightly regulated by modulating DDR
factors recruitment, retention and dissociation from the sites of DNA damage in a
spatiotemporal manner mediated by numerous reversible post-translational
modification

(PTMs)

including

phosphorylation,

ubiquitination,

SUMOylation,

methylation, acetylation, poly(ADP-ribosyl)ation, and Neddylation. In this study, I
examined the role of phosphorylation and ubiquitination in regulating the DDR
signaling at the DNA damage sites.
DNA double-strand breaks triggers a phosphorylation-mediated signaling at
the damage sites leading to histone ubiquitination in Lys63-linked manner that
recruits BRCA1-A complex to the damage sites. The A complex is comprised of
BRCA1, Rap80, NBA1, BRE, BRCC36 and the adaptor protein Abraxas, which has
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been shown previously to constitutively interact with BRCA1-BRCT (BRCA1 Cterminal) domain through its C-terminal phosphorylated S406 residue. In this study,
we found that DNA damage-induced Abraxas phosphorylation at neighboring S404
residue induces stable BRCA1 dimerization through its BRCT domain. Both crystal
structure and in vivo analysis confirmed that phosphorylation at Abraxas S404
residue is essential for stable BRCA1-BRCT dimer formation and mutation in the
S404 residue leads to impaired accumulation of BRCA1 to damaged chromatin. In
addition, we found two germline mutations in the BRCA1-BRCT dimerization
interface disrupt stable dimer formation both in vitro and in vivo.
Although phosphorylation has been shown to be the major PTM at the DSB
sites, over the last decade, ubiquitination has also emerged as a key regulatory
player in the DDR. Irradiation (IR)-induced DNA damage catalyzes Lys63-linked
polyubiquitination of histones, H2A and H2A.X that leads to accumulation of BRCA1A complex to DSBs. In my second study, we sought to determine whether nonlys63-linked ubiquitination also exists at the DSBs regulating the DDR pathway. My
findings indicate that along with Lys63-linked ubiquitination, chromatin-bound
proteins are also modified with Lys11-linked polyubiquitination at DNA damage sites
in an ATM-dependent manner by Ube2S/Ube2C E2 conjugating and RNF8 E3 ligase
enzymes and deubiquitinated by OTUD7B (Cezanne) enzyme. I further showed that
histones H2A and H2A.X is modified with Lys11-linked polyubiquitination in a DNA
damage-dependent manner that is essential for inhibiting transcriptional silencing at
proximity to DSB sites to maintain genomic stability. Overall, my findings provide
insights into how post-translational modifications regulate DDR factors dynamics at
DSB sites and play a crucial role in maintaining genomic integrity.
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CHAPTER 1
OVERVIEW OF THE DNA DAMAGE RESPONSE

1.1 Introduction:
The genomic integrity of all organisms is continually threatened by DNA
damage. The human genome regularly encounters and repairs a large number of
DNA damage lesions, estimated at 104 to 105 lesions per cell per day (1, 2).
Exogenous exposure to carcinogens, ionizing radiation (IR), or the ultraviolet light
from the sun can all damage DNA. Additionally, many cellular processes generate
endogenous sources of DNA damage. Reactive oxygen and nitrogen species
generated during cellular metabolism, misincorporation of dNTPs during DNA
replication, cytosine deamination, DNA alkylation, and abortive topoisomerase
activities all generate DNA lesions that must be repaired faithfully (2-5). Unrepaired
DNA can physically interfere with fundamental cellular processes such as replication
and transcription. Moreover, improper repair of these lesions can lead to gene
mutations, deletions, or translocations that, in turn, either inactivate tumor
suppressor genes or activate oncogenes. Together, these events trigger wide-scale
genomic instability, a characteristic hallmark of cancer development (6-8)
To combat the DNA lesions and maintain genome integrity, cells have
evolved highly orchestrated sensory signaling cascades collectively called the DNA
damage response (DDR) (Figure 1). The DDR senses DNA damage and initiates
DNA repair. Distinct protein complexes categorized as sensors, mediators,
transducers and effectors amplify the DNA damage signal, activate cell cycle
checkpoints, and initiate repair or trigger apoptosis should the defect be irreparable
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Figure 1: Organization of cellular DNA damage response pathway. Cellular
response to DNA damage from different sources involves sensing the damage
signal, amplifying and transducing the signal to mediator proteins that regulate
spatio-temporal organization of effector proteins to exert appropriate response
that involves activation of a cell cycle checkpoint, transcriptional regulation,
execution of DNA repair or induction of apoptosis in case of severe DNA
damage.
3

(2, 4, 9). Recruitment, retention and dissociation of DDR factors to and from the sites
of DNA damage are tightly regulated in a time-dependent manner to maintain
cellular homeostasis. This is mainly mediated by numerous reversible posttranslational modifications (PTMs) (10-13).
1.2 DNA repair pathways in mammalian cells
To counteract DNA damage, cells have developed lesion-specific repair
mechanisms. In mammalian cells, these constitute 4 major repair pathways: base
excision repair (BER), nucleotide excision repair (NER), mismatch repair (MMR) and
double-strand break repair pathways (Figure 2) (1). In this thesis, I examine the
complexity of DNA damage response signaling involved in irradiation (IR)-induced
DNA double-strand breaks (DSBs) and how post-translational modifications play an
essential role in regulating the DDR signaling.
DNA double-strand breaks are one of the most cytotoxic lesions experienced
by cells. If not properly repaired in a timely manner, DSBs may lead to a
chromosomal deletion or translocation, triggering genomic instability and
predisposing a cell to tumorigenesis (4, 5). Mammalian cells utilize two major repair
pathways for DSB repair – non-homologous end joining (NHEJ) and homologous
recombination (HR). In higher order vertebrates, NHEJ is the prevalent repair
pathway choice. NHEJ operates throughout the cell cycle and is known to be
inherently “error-prone”. Conversely, HR predominantly occurs during S and G2
phases of the cell cycle as it requires the presence of the sister chromatid that is
used as a homologous template for repair of the damaged DNA and is considered
as an “error- free” repair pathway (14).

4

Figure 2: Types of DNA damage and DNA repair mechanisms. The
figure illustrates sources of endogenous and exogenous DNA damages
and relevant repair pathways repair the damaged DNA.

Figure is adapted and modified with permission from (1) Cedric Blanpain,
Mary Mohrin, Panagiota A Sotiropoulou, and Emmanuelle Passegue, DNADamage Response in Tissue-Specific and Cancer Stem Cells. Cell Stem
Cell 2011 8, 16-29 2011. License number 4092160106928.
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1.3 Spatiotemporal dynamics of DDR factors at DNA damage sites:
One of the most notable features of the DNA damage response is the
assembly and disassembly of chromatin regulators and DDR factors at damaged
chromatin. This dynamic activity can be visualized by immunofluorescence as
distinct nuclear ‘foci’ using antibodies. Although the focal accumulation of DDR
proteins at damaged sites amplifies the damage signal, the functional significance of
these foci in the DDR pathway still remains unknown (10). It is important to note that
not all DDR factors assemble and dissociate from the damaged chromatin at the
same time. Rather, the assembly and disassembly of DDR factors occur in a
hierarchical fashion in a time-dependent manner. For example, while accumulation
of NHEJ repair proteins at DSB sites is rapid but transient, HR proteins show
delayed but persistent retention at damage sites, illustrating the different repair
kinetics of these two major repair pathways (15). This careful spatiotemporal
regulation of DDR factors at damaged chromatin is in large mediated by numerous
reversible post-translational modifications (PTMs). PTMs not only promote the
recruitment and dissociation of DDR factors, but also regulate their residence time at
damage sites. In DSB repair, the role of phosphorylation in initiating the DDR
signaling cascade has been described in much detail. However, recent years have
witnessed the characterization of an unprecedented number of post-translational
modifications at the sites of DNA damage including ubiquitination, SUMOylation,
Neddylation, methylation, acetylation, and poly(ADP-ribosyl)ation (10). These
findings depict more complex picture of the DNA damage response pathway at DSB
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sites. In addition, findings of cross talk between these different modifications
illustrate the intricacy of PTM signaling in the DDR (12, 16, 17)
1.4 Activation of DNA damage response following DNA double-strand breaks
Activation of DDR signaling and the efficiency of DNA repair is largely
dependent on chromosomal contexts, such as whether chromatin has an open or
compacted structure at the sites of DNA damage. At densely packed chromatin
regions, repair of damaged DNA is more difficult and takes a longer time to
complete. Several DDR kinases play an essential role in altering chromatin structure
to render damaged chromatin accessible to repair factors. In mammalian cells,
members of the phosphatidylinositol-3-kinase-like kinase family (PIKKs) – ATM,
ATR, and DNA-pkcs – act as the furthermost upstream kinases that transduce and
amplify the DNA damage signal. ATM and ATR appear to be the major kinases that
phosphorylate hundreds of substrates preferentially at S/TQ (serine/threonineglutamine) sites to activate cell cycle checkpoints, chromatin remodeling, and initiate
DNA repair (18). Although both ATM and ATR kinases share significant structural
and functional similarity and have overlapping substrate proteins involved in the
DNA damage response pathway, the activation of these two kinases requires
different stimuli (19). While ATM is primarily activated in response to DNA doublestrand breaks, ATR is activated to a broad spectrum of DNA damaging signals
including lesions generated by UV, cross-linking agents, and replication stress, in
addition to DSBs. Recent genome wide analysis reveals that ATM and ATR function
as master signal transducers in the DDR pathway, coordinating a large cellular
signaling network to maintain genomic integrity.
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ATM is activated immediately after DSBs by the sensor protein complex,
Mre11-Rad50-Nbs1 (MRN) (20-27). Following activation by MRN, ATM triggers DDR
signaling by phosphorylating hundreds of downstream proteins (18, 28). One of the
early events following ATM activation is the phosphorylation of histone variant
H2A.X by ATM at Ser139 residue. The DSB-induced phosphorylation of H2A.X
occurs immediately after DNA damage and spreads over megabases of chromatin
flanking the damage site in both directions. H2A.X phosphorylation can be detected
in cells as discrete “foci” following DSB induction by irradiation (IR) (29-31).
Phosphorylated H2A.X (γH2A.X) directly recruits the mediator protein, MDC1
(mediator

of

DNA

damage

checkpoint

1),

which

recognizes

and

binds

phosphorylated H2A.X through its BRCT domain. MDC1 also forms IR-induced foci
(IRIF) that extensively co-localizes with γH2A.X (32-34). Interestingly, MDC1 also
interacts with ATM through its FHA domain. ATM-MDC1 interaction targets activated
ATM to DSB flanking chromatin regions, thereby propagating ATM-mediated H2A.X
and MDC1 phosphorylation at damaged chromatin to amplify the damage signal. In
addition, MDC1 has been shown to regulate damage-induced cell cycle arrest
checkpoint (35, 36).
γH2A.X-MDC1 acts a molecular platform that orchestrates the recruitment of
additional DDR factors to the sites of DNA damage in a hierarchical manner (Figure
3). Phosphorylated MDC1 binds and targets E3 ubiquitin ligase RNF8 to damage
sites. RNF8 contains an FHA domain at its N-terminus and RING domain at its Cterminus. RNF8 interacts with ATM-phosphorylated MDC1 via its FHA domain.
Interestingly, RNF8 localization to damage sites is independent of its RING domain
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Figure 3: Phosphorylation-dependent ubiquitin signaling at DSB sites. DNA
double-strand breaks induces a ATM-mediated phosphorylation-dependent
ubiquitin signaling at DSB sites. Ubc13-RNF8-RNF168 enzymatic machinery
catalyzes Lys63-linked ubiquitin chain that targets 53BP1 and BRCA1-A complex at
damage sites to initiate repair.
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but requires the FHA domain, indicating that a phosphorylation-dependent
interaction with MDC1 is crucial for RNF8 accumulation to DSBs (37-39). RNF8
recruitment to damaged chromatin is consistent with earlier observations of ubiquitin
conjugation at IRIF. In addition to MDC1 binding, the RNF8 FHA domain also
interacts with another E3 ligase, HERC2, forming an MDC1-RNF8-HERC2 complex.
This complex facilitates RNF8 interaction with the E2 ubiquitin conjugating enzyme,
Ubc13, to catalyze Lys63-linked ubiquitination at damaged chromatin (40). The
RNF8-Ubc13

enzymatic

machinery

ubiquitinates

chromatin-bound

proteins,

including histone H2A and H2A.X, with non-proteolytic Lys63-linked ubiquitin chains
in a DNA damage-dependent manner. This ubiquitination triggers the recruitment of
downstream DDR factors recruitment including 53BP1 and components of BRCA1-A
complex to damaged chromatin. In addition, RNF8 depletion has been shown to
result in G2/M checkpoint arrest and hypersensitivity to IR-induced DNA damage,
indicating that RNF8-dependent ubiquitination at DNA damage sites is essential for
cells to cope with DNA double-strand breaks (37-39, 41). Later studies
demonstrated that RNF8-mediated Lys63-linked ubiquitin conjugates are recognized
by MIU (42) domains of another E3 ligase, RNF168, triggering its accumulation at
DSB sites. RNF168, in association with the Ubc13 E2 conjugating enzyme, then
amplifies the Lys63-linked ubiquitin chain on histone H2A and H2A.X, along with
other unidentified substrates. Lys63-linked ubiquitin chains on histone and other
chromatin-bound proteins are also recognized by the Ubiquitin Interacting Motif
(UIM) of Rap80, which subsequently mediates accumulation of 53BP1 and
components of BRCA1-A complex to sites of DNA damage (43-45). Recruitment of
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BRCA1 and 53BP1 at DNA damage sites regulates the balance and repair pathway
choice between HR and NHEJ at the damage sites. More recently, the Mailand
group has shown that H1-type linker histones, but not core histones, serve as the
major substrate for Ubc13-RNF8-mediated Lys63-linked ubiquitination and that
RNF168 recognizes Lys63 ubiquitinated histone H1 at damaged chromatin,
emphasizing the essential role of Ubc13 and RNF8 in recruiting RNF168 to DSBs
(46).
1.5 Role of BRCA1-A complex in DSB repair
BRCA1-A complex, named after the adaptor protein Abraxas, consists of five
different proteins: Rap80, Abraxas, NBA1, BRE, and BRCC36 (47-54). Abraxas
mediates the interaction between BRCA1 and the other components of the A
complex. The Abraxas-BRCA1 interaction is essential for Abraxas’s role in DNA
repair and maintenance of genome stability (55). Our lab and others have previously
shown that Abraxas interacts with BRCA1 through its C-terminal pSPTF motif, in
which phosphorylated Ser406 (S406) binds to BRCA1 C-terminal (BRCT) domain.
Deletion of the pSPTF motif or mutation of the S406 residue disrupts both AbraxasBRCA1 interaction and BRCA1 localization to DNA damage sites, thereby impairing
efficient DNA repair (47, 49, 51). Abraxas knockout mice generated by our lab
exhibit chromosomal instability and increased incidence of tumor development.
Interestingly, a mutation in the phenylalanine residue of the Abraxas pSPTF motif
(F409C) has been identified in human tumors (55), suggesting the importance of
Abraxas-BRCA1 interaction in tumor suppression. Yet, it still remains unknown how
Abraxas mediates BRCA1’s tumor suppression function. Of note, Abraxas S406 is
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constitutively phosphorylated in presence and absence of DNA damage (47).
Therefore, it is tempting to speculate that there may be an additional regulatory
mechanism that modulates Abraxas-BRCA1 interaction upon DNA damage.
1.6 Non Lys63-linked ubiquitination at DSB sites
Although Lys63-linked ubiquitination at damaged chromatin have been
extensively studied, emerging evidence from different groups indicate that the
ubiquitin landscape at DSB sites is much more complicated than previously
anticipated and that additional linkage-specific ubiquitin chains (such as Lys6,
Lys48, or Lys27-linked chains) exist at damaged chromatin. For instance, RNF168
has recently been shown to catalyze Lys27-linked ubiquitination at DSB sites that is
essential for the proper activation of DDR signaling and regulates the recruitment of
53BP1, Rap80 and other DDR factors (56). In addition, RNF8 has been shown to
interact with different E2 conjugating enzymes to catalyze different linkage-specific
ubiquitin chain types. For example, recent findings have demonstrated that RNF8
can catalyze both Lys63 and Lys48-linked ubiquitin chains by interacting with Ubc13
and UbcH8 E2 enzymes, respectively (37-39, 57, 58). These findings depict that
additional linkage-specific ubiquitin chain types exist at DSB sites to regulate
efficient DDR signaling. Further study of different lysine residue-linked ubiquitination
will therefore provide deeper understanding of the DDR signaling.
1.7 Transcription silencing in response to DSBs
Given DNA damage occurs in the context of chromatin structure, it potentially
interferes with transcription and therefore coordination between DNA repair and
transcription machinery is crucial for genomic stability. This coordination involves
12

chromatin organization by chromatin modulators, histone chaperones, and DDR
factors that induce transcriptional silencing in response to DNA damage (59). DNA
damage-induced transcriptional silencing was initially identified in human fibroblast
cells where RNA synthesis is significantly depressed in a rapid and transient manner
following UV-induced DNA damage (60). Following studies have shown that UVirradiation induces local transcriptional silencing in damaged nuclei and recovery of
transcription is dependent on nucleotide excision repair (NER) (60, 61). Interestingly,
RNA synthesis is also inhibited at IR-induced DSB sites marked with γH2A.X foci
(62). These findings were further confirmed by the Friedl group, who demonstrated
that the repressive H3K27me3 mark is enriched at γH2A.X-marked DSB sites with
concomitant exclusion of H3K4me3, which is associated with active transcription
(63).

Moreover,

along

with

these

repressive

chromatin

marks,

several

heterochromatin components (such as kap-1, HP1, suv39h1, and Polycomb group
(PcG) that are known to be associated with transcription repression are enriched at
DSBs (64, 65). Findings from the Elledge group suggest that PARP-dependent
chromatin remodeling also plays an integral role in transcriptional silencing at DSB
sites (66). However, the mechanistic detail of how the transcriptional silencing is
achieved in the vicinity of DSBs is still poorly understood. Using a reporter-based
assay system, a recent study has shown that transcription at the damaged sites is
inhibited in an ATM-dependent manner. ATM kinase plays an essential role in
inhibiting transcription elongation-dependent chromatin decompaction. In addition,
their findings indicate that ATM-dependent transcriptional silencing at damaged
chromatin is associated with RNF8 and RNF168 activity in a manner independent of
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Lys63-linked ubiquitination (67). However, whether additional linkage-specific
ubiquitin conjugation exists at DSB sites that play an essential role in inducing
transcriptional silencing still remains unknown. Further research is needed to provide
meaningful insights into ubiquitin-dependent transcriptional silencing at DNA
damage sites.
1.8 Objective:
PTMs have emerged as key regulatory players in DDR signaling, In this
thesis, I sought to explore two different PTMs, phosphorylation and ubiquitination, in
the DDR pathway.

In my first study, I examined how DNA damage-induced

phosphorylation of Abraxas protein induces stable dimerization of the tumor
suppressor protein, BRCA1, essential for efficient recruitment of BRCA1 to damaged
chromatin. This study gleans structural and functional insights into how AbraxasBRCA1 interaction is modulated in response to DNA damage in order to promote
BRCA1 accumulation at damage sites for effective repair and maintenance of
genomic stability. In my second study, I investigated the function of non-Lys63-linked
ubiquitination in the DNA damage response pathway. I found that, in addition to
Lys63-linked ubiquitination, chromatin-bound proteins are also modified by Lys11linked ubiquitination and that these Lys11-linked chains are essential for
transcriptional silencing at the DNA damage sites. Findings from these studies
provide mechanistic insights into the complexity of the DNA damage response
signaling, deepening our understanding of how PTMs regulate the DDR pathway to
prevent genomic instability.
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CHAPTER 2
INTRODUCTION: ABRAXAS PHOSPHORYLATION-DEPENDENT BRCA1-BRCT
DIMERIZATION AT DNA DAMAGE SITES

This chapter is based upon Wu Q*, Paul A*, Su D, Mehmood S, Foo TK, Ochi T,
Bunting EM, Robinson CV, Wang B, Blundell TL (2016). Structure of BRCA1Abraxas complex reveals phosphorylation- dependent BRCT dimerization at DNA
damage sites, Molecular Cell, 4;61(3):434-48
•

These authors contributed equally to this work.
Note: Only results generated from my study are included in the result section of
this chapter
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2.1 Introduction
The tumor suppressor BRCA1 has emerged as the master regulator of the
genome integrity. Recent proteomic and genetic studies have revealed that BRCA1
associates with large number of proteins in cells forming distinct BRCA1 complexes
in vivo to exert its function in DNA damage repair, transcription, cell cycle regulation,
replication as well as other signaling pathways to maintain genomic stability and
function as a tumor suppressor (68, 69). The majority of the hereditary breast and
ovarian cancer syndrome (HBOC) patients carry mutations in the BRCA1 gene and
to a lesser extent in the BRCA2 gene (70). HBOC patients have a lifetime risk of
developing breast and ovarian cancer of up to 60-80% and 20-40%, respectively
(71). In addition to early onset of breast and ovarian cancer, HBOC patients also
have a higher risk of developing pancreatic, fallopian tube, prostate and stomach
cancer. More than 800 clinically relevant mutations have been identified to date in
the BRCA1 gene indicating BRCA1 plays crucial role as a tumor suppressor to
maintain genome integrity (72-74). BRCA1 associates with multiple repair proteins
forming distinct subcellular complexes to exert its role as in various cellular signaling
pathways including DNA damage repair, DNA replication, DNA end resection,
transcription, and cell cycle regulation (75, 76). BRCA1 deficiency leads to defective
S phase, G2-M and spindle assembly checkpoints as well as defective DNA repair
that trigger genome instability in cells. In addition, BRCA1-associated tumors have
shown further genetic alteration that includes loss of heterozygosity of tumor
suppressor genes as well as activation of oncogenes (such as cyclin D1, c-Myc and
ErbB2) (77-79). These findings collectively indicate that BRCA1 functions as a
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master regulator in maintaining genome stability and tumor suppression.
2.1.1 BRCA1 domain organization
BRCA1 is a large protein of 1863 amino acids containing an N-terminal RING
E3 ubiquitin ligase domain and two C-terminal BRCT domains (80) (Figure 4). The
RING domain is a motif found in many E3 ubiquitin ligase enzymes and involved in
mediating protein ubiquitination. The BRCA1 RING domain mediates stable
association with BRCA1-associated RING domain protein 1 (BARD1) and BRCA1BARD1 heterodimer has been implicated in catalyzing Lys6-linked polyubiquitin
chain that is recognized but not degraded by 26S proteasome (81-84). Although
earlier studies indicated that BRCA1-BARD1 E3 ligase activity plays an essential
role for BRCA1’s tumor suppressor function, a recent study using genetically
engineered mouse model has shown that BRCA1 E3 ligase activity is not required
for its function in homologous recombination-mediated repair and tumor suppression
(85).
The BRCT domains, each containing about 100 amino acid residues and
arranged in a head-to-tail fashion, consist of three α-helices packed around four
strands of β-sheet (86). BRCA1 BRCT domain has been characterized in regulating
diverse biological processes by associating with multiple proteins forming distinct
subcellular complexes. The BRCT domain directly interacts with phosphorylated
proteins containing pSPxF (87) motif (68, 69). Using a knock-in mouse model,
Shakya et al has recently shown that mutations in the BRCA1 BRCT domain that
disrupt phosphoprotein recognition leads to tumorigenesis in mouse (85)
emphasizing that BRCT interaction with pSPxF motif-containing proteins is
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Figure 4: Domain organization of BRCA1. BRCA1 contains a RING
domain at its N-terminus, a centrally located coiled-coil domain and two
BRCT domains at its C-terminus.
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essential for BRCA1’s tumor suppressor function. Many tumor-derived clinically
relevant mutations have been identified in the BRCA1 BRCT domain. While some of
these mutations have been shown to destabilize the BRCT structure or interfere with
its binding to the pSPxF motif-containing proteins leading to cancer predisposition,
the function of a large number of BRCT domain mutations still remains to be
determined. To date, three pSPxF motif containing proteins, Abraxas, BACH1, and
CtIP, have been shown to directly interact with BRCA1 BRCT domain forming three
mutually exclusive protein complexes with specific functions, designated as A, B,
and C, respectively named after the main adaptor protein in these complexes (68).
Although how these three complexes transmit BRCA1 signal has been largely
unknown, it appears that BRCA1 involvement in these complexes plays a major role
in its tumor suppressor function.
2.1.2 BRCA1-A complex
BRCA1-A complex consists of five different proteins: Rap80, Abraxas also
known as CCDC98), NBA1 (also known as MERIT40), BRE (also known as
BRCC45) and BRCC36 (47-54). Abraxas interacts with BRCA1 BRCT domain
through its C-terminal pSPTF motif (p-S406) and thereby mediating BRCA1
interaction with the A complex. It is important to note that Abraxas does not only
interact with BRCA1 but also bridges interaction with other members in the A
complex. Therefore, Abraxas appears to serve as a central adaptor protein in the A
complex.
As described in chapter 1, DNA damage induces ATM-dependent signaling
cascade at the damaged chromatin. One of the earliest events in the DDR activation
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is phosphorylation of histone H2A.X (γH2A.X) by ATM kinase. This leads to
phosphorylation-dependent downstream signaling cascade that culminates with
ubiquitination of histone H2A and H2A.X in Lys63-linked manner by Ubc13
conjugating enzyme and RNF8/RNF168 E3 ubiquitin ligases (37-39, 41, 43, 45). The
Lys63-linked polyubiquitin chain is recognized by the Ubiquitin Interacting Motif
(UIM) of Rap80 that interacts with Abraxas and subsequently, the BRCA1-A
complex is localized to the damaged sites. It is important to note that NBA1 and BRE
interaction is essential for the integrity of the A complex (88). In addition, BRCC36 in
the BRCA1-A complex contains catalytically active MPN+/JAMM domain, a domain
found in zinc metalloprotease deubiquitinating enzymes (DUBs) (89) and cleaves
Lys63-linked polyubiquitin chain at DSB sites (90, 91). Importantly, the BRCA1-A
complex shares significant similarity with the lid of the 19S proteasome regulatory
complex, which cleaves the polyubiquitin chain of substrates and facilitates entry into
the proteasome core for proteolytic degradation (53). Since BRCC36 has
deubiquitinating activity only towards Lys63-linked polyubiquitin chain, it appears
that the BRCA1-A complex assembly at the DNA damage sites serves as a DUB
complex to facilitate DUB activity of BRCC36 (53).
2.1.3 Abraxas-BRCA1 interaction is essential for tumor suppression and
maintaining genome stability
Mass-spec-based analysis from our lab and others identified Abraxas as a
BRCA1- BRCT interacting protein. Abraxas co-localizes with BRCA1 and is essential
for BRCA1 recruitment to IR-induced DSB sites. Both in vitro and in vivo biochemical
analysis confirmed that Abraxas interacts with BRCA1 BRCT domain through its C-
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terminal pS406PTF motif in which Ser406 phosphorylation is essential for BRCTAbraxas interaction. Deletion or S406A mutation in the motif impairs BRCA1
interaction with Abraxas resulting defective BRCA1 localization to IR-induced DSB
sites. Abraxas deficient cells showed hypersensitivity to IR and UV-induced DNA
damages. Moreover, in consistent with BRCA1’s function in homologous
recombination (HR)-mediated DNA repair and cell cycle regulation, Abraxas
deficient cells also showed defects in HR repair and G2-M checkpoint (47, 49).
Because Abraxas interacts with BRCA1 and this interaction is essential for BRCA1’s
function in maintaining genome stability, our lab has generated Abraxas knockout
mouse to examine whether Abraxas functions as a tumor suppressor in vivo. We
found that Abraxas knockout mice exhibit chromosomal instability and increased
tumor incidence developing lymphomas and tumors of other origins. Furthermore,
bioinformatics analysis of human tumors from TCGA and COSMIC databases
revealed Abraxas gene expression is lost/reduced in multiple types of cancers
including breast and ovarian cancer. Along with copy number loss or reduced
expression, this analysis identified somatic mutations of Abraxas in endometrial,
lung, colon, liver, kidney and leukemia (Figure 5). Of note, among 26 mutations
found in Abraxas gene, six mutations were found to generate C-terminal pSPTF
motif truncated products that cannot bind to BRCA1 protein highlighting the
importance of this motif in interacting with BRCA1. Collectively, these findings
suggest that Abraxas is a bona fide tumor suppressor and highlight the importance
of Abraxas-BRCA1 interaction in DNA repair and maintaining genome stability (55).
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2.1.4 Role of Abraxas phosphorylation in regulating Abraxas-BRCA1
interaction
Abraxas pSPxF motif at the C-terminus contains phosphorylated S406
residue that mediates interaction with BRCA1 and mutation in this residue (S406A)
abrogates this interaction. Interestingly Abraxas S406 is constitutively
phosphorylated even in absence of DNA damage. This raises the question of “how
BRCA1 BRCT-Abraxas interaction is regulated in presence of DNA damage?” To
address this, we analyzed the C-terminal sequence of Abraxas adjacent to the
pS406PTF motif. Sequence analysis of the Abraxas C-terminal revealed that an
additional Ser residue (S404) located adjacent to S406 in the pSPxF motif. Given
the close proximity of this Ser404 residue to Ser406 in the pSPxF motif, we reason
that this residue may regulate BRCA1 BRCT-Abraxas interaction. Mass-spec
analysis of BRCA1-BRCT domain showed that double-phosphorylated Abraxas
peptide containing phosphorylated S404 and S406 (pS404pS406) bound to BRCT
and was enriched significantly upon IR-induced DNA damage, while the singly
phosphorylated pS406 containing peptide bound to BRCT domain but was not
enriched after IR (47). These findings indicate that while constitutive S406
phosphorylation is required for interaction with BRCA1, S404 phosphorylation may
have some additional functional significance in regulating interaction with Abraxas.
To gain further insights into Abraxas-BRCA1 interaction our lab generated an
antibody that can specifically recognize doubly phosphorylated S404S406. The
pS404pS406 specific antibody can detect Abraxas in control cells but not in Abraxas
KO HEK293T cells. The double phosphorylation of Abraxas is abrogated in cells
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(Figures 2E–2G). Extra electron density corresponding to the (Varma et al., 2005) shows similar pSPxF-moti
phosphate group of pS404 and the side chain of Y403 is ever, compared to Bach1 and CtIP, the N-ter
observed only in BRCT-Ab2p. Unlike pS406, the pS404 phos- of Abraxas in both BRCT-Ab1p and BRCT-Ab2p

expressing S404A, S406A as well as S404AS406A double mutant (Figure 6). We
tested Abraxas phosphorylation status using the doubly phosphorylated antibody as
well as previously generated phosphorylated S406 antibody. As shown in Figure 6,
while the band intensity of pS406 antibody did not change after DNA damage; using
pS404pS406 antibody we detected Abraxas band intensity increased in a timedependent manner up to 1 hour post-IR followed by gradual gradually decrease to
the basal level at later time-points. Furthermore, we found that pS404pS406 band
intensity increased in DNA dose-dependent manner. Since phosphorylation at S406
did not change after IR treatment, these results indicate that phosphorylation at
S404 is likely to be IR-induced (87).
2.1.5 DNA damage-induced ATM-dependent phosphorylation of Abraxas at
S404
Since the apical kinase ATM plays a crucial role in the IR-induced DNA
damage response pathway that recruits BRCA1 and components of the BRCA1-A
complex at the sites of DNA damage, we tested whether Abraxas phosphorylation at
S404 is ATM-dependent. Cells treated with ATM inhibitor KU55933 showed
complete disruption of S404 phosphorylation indicating IR-induced Abraxas
phosphorylation at S404 is an ATM-dependent event (Figure 7). On the other hand
inhibiting the cells with ATR appeared to have minimal effect on the IR-induced
phosphorylation as detected by the pS404pS406 antibody (Figure7) (87).
2.1.6 Crystal structure of BRCA1 BRCT domains in complex with single and
double-phosphorylated Abraxas phosphopeptides
To mechanistically dissect the role of S404 phosphorylation in BRCT-Abraxas
26

interaction, we solved the crystal structure of BRCA1 BRCT domain with single
(pS406) or double (pS404pS406) phosphorylated phosphopeptide. This work was
done in collaboration with Dr. Tom Blundell’s lab, University of Cambridge, UK by Dr.
Qian Wu (87). The crystal structures of BRCT with both single and double
phosphorylated Abraxas phosphopeptides were solved at 3.5 Å resolution.
Consistent with previously solved BRCT crystal structure with BACH1 and CtIP, the
two BRCT domains of BRCA1 (BRCT1 and BRCT2) associate in a head-to-tail
fashion. In each domain, a four-stranded parallel β sheet is surrounded by three α
helices. The Abraxas pSPxF motif interacts with BRCT domains in a two-anchor
mode where S406 and F409 of the pSPxF interact with residues in the BRCT
domains (Figure 8).
Importantly, the crystal structure data of BRCA1 BRCT with single
phosphorylated S4046 (termed as BRCT-Ab1p) and double phosphorylated
S404S406 (termed as BRCT-Ab2p) revealed unique differences in the conformation
of Y403S404R405 region, which is located adjacent to the pSPTF motif in Abraxas.
Extra electron density corresponding to the phosphate group of phosphorylated
S404 and the side chain of Y403 was observed in the case of BRCT-Ab2p but not in
the case of BRCT-Ab1p (Figure 8C & D). In addition, unlike BRCT-Ab1p, in the
BRCT-Ab2p complex, we found that the pS404 is oriented away from the BRCT
domain into the solvent region. The change in pS404 conformation fixes the side
chain of Y403 that generates additional interaction with BRCT K1671 residue
forming a hydrophobic interaction at the N-terminus of BRCT α1. Additionally, the
negative surface region formed by the phosphate group of pS404
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and side chain E402 leads to cross interaction with BRCT K1671 (Figure 8E) (87).
Collectively, these events promote stable dimerization of the BRCT-Ab2p complex
involving α1 and β2 of the BRCT1 domain and the Ab2p (Figure 9A). α1 of the
BRCT1 domain form hydrophobic interaction between α1 helices (α1- α1) and
extensive hydrogen bonding between the two antiparallel β strands (β2- β2) (Figure
9). At the dimerization interface, we found two of the α1 helices from each BRCT1
domain form isologous interactions burying a hydrophobic patch formed by F1662,
M1663 and Y1666 residues with hydrophobic side chains stacking on each other
(Figure 9B). Importantly, two of three residues (F1662 and M1663) in the BRCT
dimerization interface were identified as BRCA1 germline mutations (F1662S and
M1663K) in the Breast Cancer Information Core database (92) suggesting that
mutations in these residues may disrupt the stable dimer structure and thereby
impairs BRCA1’s role as tumor suppressor.
2.1.7 BRCT-Ab2p complex forms a dimer in vitro
BRCA1 BRCT-Abraxas dimerization was examined in vitro by size-exclusion
chromatography in collaboration with Dr. carol Robinson’s lab at the University of
Oxford. The gel filtration analysis obtained from BRCT-Ab1p and BRCT-Ab2p
complexes revealed that compared to the elution peak for BRCT-Ab1p complex,
which aligns with BRCT-Bach1 and BRCT-CtIP complexes, the peak for BRCT-Ab2p
complex shifted to the left of the BRCT-Ab1p suggesting a larger hydrophobic radius
and a possible higher order complex. And according to the protein size markers, the
size of BRCT-Ab2p appeared to be roughly double to that of the BRCT-Ab1p
complex (Figure 10A). Moreover, measuring the exact molecular weight of peak
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fractions eluted from size exclusion chromatography by using nano-electrospray
mass spectrometry under native conditions showed while BRCT-Ab1p complex
appeared to exist predominantly as a 1:1 monomer with a small fraction forming 2:2
dimer, the BRCT-Ab2p was found to exist mostly as 2:2 complexes, indicating a
much stable dimer formation. BRCT-Bach1 and BRCT-CtIP were detected as 1:1
monomeric complexes similar to BRCT-Ab1p complex (Figure 10 B-E) (87).
Collectively, these findings indeed confirm the crystal structure data that doubly
phosphorylated Abraxas phosphopeptide induces stable dimerization of BRCA1
BRCT-Abraxas complex.
2.1.8 Abraxas S404 phosphorylation is essential for stable BRCA1 BRCTAbraxas complex dimerization
In order to corroborate functional significance of Abraxas S404
phosphorylation in inducing stable dimerization, mutational analyses were performed
using S404P and S404D mutants. Size exclusion chromatography with
phosphomimetic S404D mutant revealed BRCT-Ab1p (S404D) can maintain 2:2
dimer complex, while BRCT-Ab1p (S404P) led to the formation of 1:1 complex
(Figure 11A). These findings highlight the functional significance of S404
phosphorylation. In addition analysis of the N-terminal sequence of the pSPTF motif,
which includes GFGEYS404RS406PTF, revealed while GFGE is not absolutely
required for the dimer formation, the presence of this sequence stabilizes the dimer
structure (data not shown).
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Figure 10. Double phosphorylated Abraxas phosphopeptide induces
dimerization of BRCT-Ab2p complex. A. Size exclusion chromatography of
BRCT complex with Ab1p, Ab2p, BACH1 and CtIP phosphopeptides. The
regions for dimer complex (2:2 complex) and monomer complex (1:1 complex)
are high lined in yellow and gray shades. (B-E) The native mass spectra of
BRCT-Ab1p (B), BRCT-ab2p (C), BRCT-Bach1 (D), and BRCT-CtIP (E)
complexes tested at 15 uM.
In vitro data were collected by collaborators Dr. Tom Blundell’s group, University
of Cambridge and Dr. Carol Robinson’s group, University of Oxford.
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2.1.9 Germline mutation in the BRCT dimerization interface disrupts stable
BRCT-Ab2p complex dimerization in vitro
The crystal structure data revealed that the BRCT dimerization involves α1
and β2 of the BRCT1 domain forming hydrophobic interaction between α1 helices
(α1- α1) and extensive hydrogen bonding between the two antiparallel β strands (β2β2) (Figure 9). The α1- α1 dimerization interface consists of hydrophobic patch
formed by F1662, M1663 and Y1666 amino acids with aromatic side chains stacking
on each other (Figure 9B). As discussed in section 2.1.6, F1662 and M1663
residues were identified as germline mutations as F1162S and M1663K in cancer
patients (92). To understand whether α1- α1 interaction contributes more significantly
than β2- β2 interaction in stabilizing the dimer interface, size-exclusion
chromatography was carried out with mutants that disrupt the β2- β2 and α1- α1
interaction. While the BRCT N1678A-Ab2p complex appeared to have minimal effect
in destabilizing the dimer structure, the germline mutations F1662S and M1663K led
to complete disruption of the dimer formation. BRCT Y1666A mutation did not
appear to have much role in the stability of the dimer structure as the elution peak
was detected between 2:2 and 1:1 complexes (Figure 11B). Collectively these
results support our crystal structure results that F1662S and M1663K mutants
disrupt the dimer stability indicating these residues likely play a crucial role in
BRCA1’s tumor suppressor function (87).
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2.1.10 Abraxas dimerization/oligomerization in cells is independent of BRCA1
binding
The findings from this study led us to question whether Abraxas also forms a
dimer in which the phosphorylated C-termini of Abraxas in complex with BRCA1BRCT could be in close proximity for dimerization. To test this, differentially tagged
Abraxas molecules, either WT or S404A and S4046A, were immunoprecipitated and
detected by western blot analysis. As shown in Figure 12A, both WT and S404A as
well as S406A, mutant interact with differentially tagged counterpart suggesting that
mutation in S404 or S406 does not disrupt Abraxas dimerization and that Abraxas
dimerization is independent of its binding to BRCA1. To further examine the domain
required for Abraxas dimerization, Abraxas truncation mutants were generated and
tested for binding to its counterpart. Importantly, we found that deletion of the
coiled-coil domain in Abraxas disrupts its self-interaction with both WT or coiled-coil
deletion mutant (Figure 12B). Taken together, these findings suggest that Abraxas
dimerization/oligomerization occurs independently of BRCA1 BRCT dimerization
through its coiled-coil domain.
2.1.11 Objective
Although BRCA1 was cloned more than 20 years ago, the exact mechanism
of how it functions as a tumor suppressor still remains to be determined. BRCA1
BRCT domain serves as a phosphopeptide-binding module that recognizes pSPXF
motif containing proteins including Abraxas, BACH1, and CtIP, forming three
mutually exclusive complexes termed as A, B and C complex, respectively. The
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phosphopeptide binding ability of BRCA1 BRCT domain is essential for its tumor
suppressor function and has been shown to harbor many clinically important breast
and ovarian cancer mutations that lead to early onset of breast cancer in patients
(Source: National Cancer Institute) (85, 93, 94). Therefore structural and functional
analysis of the BRCA BRCT binding with pSPxF motif containing proteins is
essential to understand the tumor suppressor function of BRCA1. Structural analysis
of BRCA1-BRCT in complex with other pSPxF motif containing proteins, BACH1 and
CtIP, has been solved previously providing a valuable structural framework into this
interaction (94-97). However, a detailed structural analysis of BRCA1 BRCTAbraxas interaction still remains largely unknown. The interaction of Abraxas with
BRCA1 is essential for BRCA1 recruitment to DNA damage sites and maintenance
of genome stability. The significance of Abraxas pSPxF motif interaction with BRCA1
BRCT in tumor suppression is exemplified by identification of an Abraxas mutation in
tumor harboring F409C (55). In this study, we employed in vitro analysis to solve the
crystal structure of BRCT-Abraxas complex that showed that phosphorylation at
S404 residue induces stable dimerization of BRCT-Abraxas complex. Moreover, at
the BRCT dimerization interface we found two germline BRCA1 mutations that
destabilized the dimer structure in vitro. However, there are several questions that
arise from these in vitro findings. First, “What is the functional significance of
Abraxas S404 phosphorylation in terms of BRCA1 localization to damage sites?”
Second, “Does BRCA1 dimerization occur in vivo through its BRCT domain?” And
third, “Does BRCA1 dimerization in vivo in Abraxas-dependent manner?”
Addressing these questions will not only validate our in vitro findings of BRCT-
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Abraxas complex dimerization but will also provide insights into the functional
significance of DNA damage-induced Abraxas S404 phosphorylation in regulating
BRCA1 dimerization at the DNA damaged chromatin, deepening our understanding
of Abraxas and BRCA1 tumor suppressor function to maintain genome stability.
2.2. Materials and Methods
2.2.1 Cell culture
All cell lines were maintained using standardized methodology in sterile
condition. U2OS cells were grown in McCoy’s 5A medium (Corning) supplemented
with 10% fetal bovine serum (FBS) and maintained at 370C with 5% CO2
atmosphere. HEK293T cells were cultured in DMEM (Corning) supplemented with
10% FBS.
2.2.2 Generation of stable cell lines
To generate Abraxas knockdown cells complemented with WT or mutant
Abraxas, U2OS cells were infected with retrovirus containing shRNAs against
Abraxas followed by selection with puromycin (0.8 ug/ml) for 5 days. The Abraxas
knockdown stable cell line was then complemented with expression of empty MSCV
vector or expression constructs containing HA-tagged WT or mutant Abraxas, and
selected with Blasticidin (9 ug/ml) 1 week for stable expression. Abraxas knockdown
efficiency and complementation with HA-tagged Abraxas was confirmed by western
blot with Abraxas and HA antibodies.
2.2.3 Cell lysis and Western blot
Cell lysis and western blot analyses were performed using established
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methodology. Cells were lysed in NETN buffer (50 mM Tris-HCl, pH 8.0, 150 mM
NaCl, 1 mM EDTA, 0.5% Nonidet P-40) with protease inhibitors (98) and protein
phosphatase inhibitors, 1 mM NaF, and 1 mM Na3VO4. Cells were lysed on ice for
atleast 30 minutes followed by brief sonication (Bioruptor) and centrifuged at 13,200
rpm to remove cellular debris. Protein concentration was measured by Bradford
assay and 50 µg protein lysate were used for western blot analysis. Samples were
run in 10% SDS-PAGE gel and run at 90 volts for 2-3 hours in a Biorad MiniPROTEAN electrophoresis chamber using running buffer followed by transfer into
nitrocellulose membrane using cold transfer buffer. The membranes were blocked
with 4% milk for at least 20 minutes followed by incubation with primary and
secondary antibodies. Blots were washed at least 4 times after each antibody
incubation and developed using ECL-plus chemiluminescent detection reagent
(Promega).
2.2.4 Immunofluorescence
Abra1 shRNA knockdown cells complemented with empty vector, wild type or
mutants of Abraxas were analyzed for BRCA1 IR-induced foci formation (IRIF).
Following 10 Gy irradiation from a 137Cs source, cells were incubated at 370C for 2
hours. Cells were then fixed with 3.6% formaldehyde for 10 min, permeabilized with
0.5% Triton X-100 solution, and incubated with primary antibodies for 1 hr at 370C
followed by appropriate Alexa 488-conjugated (green; Invitrogen) and Alexa 555conjugated (red; Invitrogen) secondary antibodies. At least 500 cells were counted
for each cell type and cells containing more than 10 foci were counted as positive.
All images were obtained with a Nikon TE2000 inverted microscope with a
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Photometrics Cool- Snap HQ camera. Quantification of BRCA1 was performed using
Imaris software (Bitplane). The DAPI channel was used to select the nuclei of the
cells in the field, red and green channel were used for BRCA1 and γH2AX,
respectively. For BRCA1 foci intensity measurement, foci were defined as particles
bigger than 0.25 µM in diameter with an intensity cut-off value (1200) to eliminate
background. At least 50 cells were counted and plotted using GraphPad Prism
software. Statistical analysis was performed by student’s t-test or ANOVA with
Tukey’s multiple comparisons test. p-value is as indicated.
2.2.5 Coimmunoprecipitation
Cells were lysed in NETN buffer containing protease inhibitor and
phosphatase inhibitor. For Flag IP, cell lysates were incubated with Flag beads (98)
overnight with gentle agitation at 4oC. The beads were washed with NETN lysis
buffer four times and eluted with 3X sample buffer for Western blot analysis. For
analyzing Abraxas dimerization in vivo, GFP-tagged and HF- tagged Abraxas
wildtype, S404A, S406A mutant or coiled-coil deletion mutant were transiently
transfected to 293T cells. Two days after transfection, cells were either untreated or
exposed to 10 Gy IR. 2 hr later, cells were collected for GFP- or Flag- IP and
Western blot was probed with either antibodies against HA or GFP. For analyzing
BRCA1 dimerization in vivo, Flag- or Myc-tagged BRCA1 full-length wild type or
mutants, or HA- and Myc-tagged BRCA1 BRCT fragments were analyzed in a
similar way.
2.2.6 Clonogenic survival assay
Abra1 shRNA knockdown cells complemented with empty vector, wild type or
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mutants of Abra1 were analyzed for cell survival in response to IR. Stable U2OS cell
lines were seeded at low density in 10 cm dishes and irradiated with 4 Gy ionizing
irradiation using a 137Cs source. The cells were then cultured at 37°C for 14 days to
allow colonies to form. Colonies were stained with 2% methylene blue and 50%
ethanol for 10 min. Colonies containing 50 or more cells were counted as positive
and statistical data were analyzed by analysis of variance (99) with Tukey’s multiple
comparisons test.
2.2.7 Chromatin fractionation
Cells were irradiated at 10 Gy followed by 1 hr incubation at 370C. For total
cell extracts, cells were lysed in NETN150 buffer containing protease inhibitor
mixture and analyzed by Western blot. For chromatin fractionation, irradiated cells
were washed in PBS and resuspended in Buffer A (10 mM Hepes pH 7.9, 10 mM
KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 5 mM NaF, 1 mM Na3VO4 , 1
mM dithiothreitol (DTT), and protease inhibitor mixture) containing 0.1% Triton X100, and incubated on ice for 5 min for permeabilization. The cytosolic fraction was
then separated by centrifugation at 4000 rpm for 5 min at 4°C. The supernatant was
discarded and the nuclei pellet was washed once with Buffer A and resuspended in
Buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT, protease inhibitor mixture) and
incubated for 30 min on ice. The soluble nuclear fraction was separated by
centrifugation at 4500 rpm for 5 min. The chromatin fraction pellet was washed with
Buffer B and resuspended in 100 µl Laemmli sample buffer and sonicated for 10 sec
before analysis.
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2.3 Results
2.3.1 Generation of Abraxas knockdown cells complemented with WT or
mutant Abraxas
As discussed in section 2.1.5, while S406 is constitutively phosphorylated
even in absence of DNA damage, we found DNA damage triggers ATM-dependent
phosphorylation at S404 residue in DNA dose- and time-dependent manner (Figure
13A). To dissect functional significance of S404 phosphorylation in the DDR
pathway, I stably knocked down Abraxas in U2OS cells using retrovirus-encoding
shRNAs targeting endogenous Abraxas. These cells were then complemented with
shRNA-resistant HA-tagged WT, S404A or S406A mutants of Abraxas. The
knockdown efficiency and complementation with above-mentioned constructs were
confirmed by western blot analysis with Abraxas antibody (Figure 13B). Tubulin was
used as loading control.
2.3.2 Increased cellular sensitivity to IR-induced DNA damage of Abraxasdeficient cells expressing mutants of Abraxas.
Since S404 is phosphorylated in DNA damage-dependent manner that likely
plays a role in stable BRCT-Abraxas dimerization in cells, I tested whether S404
phosphorylation is critical for the function of Abraxas in response to IR. To test this I
measured the cellular sensitivity of Abraxas knockdown cells expressing WT or
mutant Abraxas. As shown in Figure 13, I found consistent with previous findings
Abraxas depleted cells become hypersensitive to IR-induced DNA damage.
Interestingly while complementing these cells with WT Abraxas can rescue the
defects in cellular sensitivity, both S404A and S406A mutant expressing cells were
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cellular resistance to IR. A. Abraxas stable knockdown cells complemented with
vector, WT, S404A or S406A were generated as described in materials and method.
Western blot analysis was performed with Abraxas antibody to confirm knockdown
efficiency and expression of HA-Abra1 constructs. B. Increased cellular sensitity to

IR-induced DNA damage in Abraxas-deficient cells expressing mutant Abraxas.
Colony survival assay was carried out for cells treated with 4 Gy IR. The data
represented means ± SD.
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were unable to fully rescue the defect. These findings suggest that phosphorylation
at plays a role in cellular resistance to IR-induced DNA damage.
2.3.3 Abraxas phosphorylation is essential for efficient recruitment of BRCA1
to DSB sites
Previous findings from our lab showed that Abraxas is essential for efficient
recruitment of BRCA1 to DNA damage sites and BRCA1 localization is disrupted in
Abraxas KO MEF cells (55). To test whether Abraxas phosphorylation plays any role
in BRCA1 recruitment to DNA damage sites, I used Abraxas knockdown cells
complemented with WT or S404A and S406A mutants of Abraxas. These cells were
irradiated with IR (10 Gy) and immunostained two hours post IR treatment to
examine whether IR-induced foci formation (IRIF) of BRCA1. As shown in Figure
14, the BRCA1 foci formation decreased significantly upon Abraxas depletion. While
the defect can be rescued by expression of HA-tagged WT Abraxas; S404A or
S406A mutants of Abraxas can only partially rescue the defect. Quantification of
BRCA1 foci positive cells indicate that compared to WT Abraxas cells showed
neither S404A or S406A mutant expressing cells can completely rescue the defects
in BRCA1 IRIF. In addition, I measured the intensity of BRCA1 IRIF in these cells.
Consistent with reduced foci positive cells, both S404A and S406A expressing cells
showed decreased overall BRCA1 foci intensity compared to WT Abraxas
expressing cells.
2.3.4 BRCA1 accumulation at damaged chromatin requires both S404 and
S406 phosphorylation of Abraxas
To further validate the defects of BRCA1 localization to IR-induced foci in
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Abraxas phosphorylation-deficient mutant expressing cells, I isolated chromatin
fraction from Abraxas depleted cells complemented with WT or phosphorylationdeficient mutants (S404A, S406A or S404AS406A) 1-hour post-IR and analyzed for
accumulation of BRCA1 to damaged chromatin by western blot analysis.
Consistently, I observed that depletion of endogenous Abraxas impaired BRCA1
loading onto damaged chromatin. While expression of WT Abraxas in Abraxas
knockdown cells can rescue the defect, cells expressing S404A and S406A single
mutants or S404AS406A double mutant of Abraxas failed to accumulate BRCA1
onto damaged chromatin (Figure 15). This was not due to change in altered
expression of BRCA1 in these cells since the total BRCA1 protein level was not
affected in Abraxas knockdown cells or knockdown cells complemented with WT or
mutant Abraxas as shown in the total cell lysate (Figure 15 bottom panel). Orc2 was
used as a marker for chromatin fraction. Collectively, these results suggest that DNA
damage-induced Abraxas S404 phosphorylation likely plays a crucial role in BRCA1
accumulation to damaged chromatin.
2.3.5 Abraxas-dependent dimerization of BRCA1 in vivo
Our crystal structure data revealed that BRCA1 BRCT dimerizes in presence
of doubly phosphorylated Abraxas phosphopeptide through the BRCT1 domain
(Figure 9). To test whether BRCA1 BRCT dimerizes in vivo and whether this
dimerization depends on Abraxas, I co-expressed differentially Myc or Flag-tagged
BRCA1 full-length constructs in 293T parental cells or Abraxas KO cells. These cells
were irradiated, incubated at 370C for 1 hour and subjected to coimmunoprecipitation analysis with Flag beads. To test whether Myc-tagged BRCA1
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interacts with its Flag-tagged counterpart, I performed immunoblot analysis with Myc
antibody to detect BRCA1 dimerization. The findings indicate that BRCA1 indeed
dimerizes in vivo and this dimerization decreased significantly in Abraxas KO cells
indicating that BRCA1 dimerization occurs in an Abraxas-dependent manner (Figure
16A). The Input western blot showed similar expression of BRCA1 constructs in both
control and Abraxas KO cells confirming that the decreased BRCA1 dimerization in
the KO cells was not due to reduced expression of any of the constructs. The band
intensity of myc-BRCA1 was quantified by densitometric analysis using NIH ImageJ
software. The normalized value (Immunoprecipitated myc-BRCA1 over Input) was
shown in the bar graph.
To further confirm whether this dimerization takes place through the BRCT
domain of BRCA1, I performed a similar co-immunoprecipitation experiment with
differentially Myc- or HA-tagged BRCT domain only constructs in 293T parental and
Abraxas KO cells. In consistent with full-length BRCA1 dimerization, I found that a
BRCA1 BRCT domain also dimerizes in vivo and this dimerization is also
significantly impaired in Abraxas KO cells (Figure 16B). In sum, these findings
validate our in vitro crystal structure findings that BRCA1 indeed dimerizes in vivo in
Abraxas-dependent manner.
2.3.6 BRCA1 germline mutations disrupt dimerization in vivo
Our crystal structure data revealed that germline mutations in the BRCT dimerization
interface, F1662S, and M1663K, disrupt the dimer stability. To test whether these
mutations interfere BRCA BRCT dimerization in vivo, I compared the interaction of
Myc-tagged full-length BRCA1 and HA-tagged wild-type BRCT fragment with that of
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the F1662S or M1663K mutant of BRCA1 and a mutant BRCA1 BRCT fragment with
three residues localized in the dimer interface mutated (F1662S/M1663K/R1670E).
and performed both Myc-IP and reciprocal HA-IP experiments to confirm if
dimerization in impaired when these critical residues in the dimer interface are
mutated. Findings from these experiments showed that while the WT BRCA1 and
BRCT can efficiently interact, the interaction/dimerization of BRCA1 and BRCT
fragment was decreased significantly when these residues were mutated. The band
intensity was quantified by densitometric analysis using NIH ImageJ software. The
normalized value (IP over Input) was shown in the bar graph (Figure 17).
Collectively, these findings suggest that F1662S and M1663K germline mutations
interfere with stable dimer formation in vivo highlighting the importance of these
critical residues in BRCA1 dimerization.
2.4 Discussion
BRCA1 accumulation to DNA damage sites is essential for its function in DNA
repair and cell cycle regulation and thereby maintaining genomic integrity. Although
phosphorylated S406 residue in the pSPxF motif of Abraxas has been shown to be
crucial in interaction with BRCA1, a detailed molecular understanding of AbraxasBRCA1 BRCT interaction still remained to be determined. In this light, our study
provides evidence for DNA damage-induced ATM-dependent mechanism for
Abraxas-mediated BRCA1 accumulation to DNA damage sites. In this, IR-induced
ATM-dependent phosphorylation of S404 residue adjacent to pSPxF motif acts as a
regulatory switch inducing stable dimerization of BRCA1 BRCT-Abraxas complex
that is essential for efficient recruitment of BRCA1 to damaged chromatin (Figure 18)
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Our crystal structure data revealed that while phosphorylated S406 phosphopeptide
of Abraxas interacts with BRCT fragment forming a monomeric complex similar to
other pSPxF motif containing proteins, doubly phosphorylated Abraxas
phosphopeptide (pS04pS406) induces stable dimerization of the BRCT domain,
mediated through the BRCT1 domain. The dimerization interface formed by two
BRCT1 domains does not interfere with pSPxF motif binding that binds to BRCT
domain as “two-anchor mode” where S406 and F409 interact with BRCT1 and
BRCT2 domains, respectively. However, the interaction between two BRCT1
domains is not sufficient to form a stable dimer in solution as observed with BRCT
domain only or BRCT domain with pS406 Abraxas, BACH1 and CtIP
phosphopeptides. On the other hand, under the same condition, in presence of
doubly phosphorylated Abraxas phosphopeptide (pS404pS406), BRCT undergoes
stable dimerization indicating that residues adjacent to pSPxF motif confer specificity
for BRCA1-Abraxas complex dimerization. Consistent with this, we found that along
with pS404, the N-terminal region of pSPxF motif (GFGE402Y403pS404RpSPVF) also
contributes to stability of the BRCT-Abraxas complex. Therefore, the unique amino
acid sequence at the C-terminus of Abraxas allows stable dimerization of BRCTAbraxas complex but not with pSPxF motif containing BACH1, and CtIP proteins.
Because of the symmetric pairing among F1662, M1663, and Y1666 residues of two
BRCT1 domains, we refer this interaction as ”pair-hugging” mode, where the
pS404pS406 phosphopeptide stabilizes the interaction. Consistent with these in vitro
data, compared to WT Abraxas, expression of S404A and S406A mutants of
Abraxas in Abraxas-deficient cells showed decreased BRCA1 accumulation to DSB
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immunoprecipitation (B). The band intensity was quantified using ImageJ
software and normalized value was shown in the bar graph.
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sites at IR-induced foci as well as decreased accumulation of BRCA1 to damaged
chromatin. With these findings, it is tempting to speculate that S404 phosphorylationinduced BRCA1 BRCT dimerization may lead to increased concentration of BRCA1
at the sites of DNA damage, which is likely essential for efficient DNA damage
signaling and repair.
In an attempt to examine how this dimerization takes place in vivo, we found
that Abraxas forms homodimer through its coiled-coiled domain at the C-terminus.
This likely brings two BRCT domains interacting through the pS406 of the pSPxF
motif of Abraxas in close proximity and therefore forming an unstable dimer. Since
S404 is phosphorylated only in presence of DNA damage in an ATM-dependent
manner, IR-induced DNA damage promotes a much more stable dimerization of the
BRCT1-Abraxas complex. Of note, Abraxas coiled-coil domain has been shown to
form a heterodimer with BRCC36 coiled-coil domain (41). Therefore it appears that
in the A complex, BRCC36 and Abraxas form an oligomeric bundle through the
coiled-coil domain present in each of them. Detail structural and cellular analysis of
the oligomeric complex in future will provide valuable insights into how BRCA1-A
complex is assembled at the DNA damage sites.
What is the functional significance of the BRCA1 BRCT dimerization in terms
of BRCA1’s role as a tumor suppressor? Our in vitro and in vivo analysis confirmed
that the germline mutations in the BRCT dimerization interface destabilize the dimer.
While many tumor-derived mutations have been reported in the BRCA1 BRCT
domain (72-74), function of large majority of these mutations is still remained to be
determined. In this light, our analysis revealed that germline mutations, M1663K,
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and F1662S, disrupt the BRCA1 BRCT dimerization and provide an explanation of
how these residues play a crucial role in the tumor suppressor function of BRCA1.
Future studies examining whether these mutations in the dimerization interface
leads to defective DNA repair or inefficient BRCA1 loading onto damaged chromatin
will provide valuable insights deepening our understanding of how Abraxas and
BRCA1 function in tumor suppression and maintenance of genome stability.
In brief, this study reveals a novel mechanistic view of DNA damage-induced
Abraxas phosphorylation-dependent BRCA1 accumulation to DNA damage sites.
The structural insights of the BRCA1-Abraxas interaction will aid in designing small
molecules in future modulating this interaction for potential therapeutic intervention.
2.5 Future direction
Although BRCA1 was identified as a tumor suppressor almost 20 years ago,
the full spectrum of its functional significance is still being elucidated. While
mutations in the BRCA1 gene predisposes women to breast and ovarian cancer
along with higher risk of developing other types of cancers, the exact role of BRCA1
in tumor suppression still remains a mystery. Solving this mystery has been a
challenge given BRCA1 associates with multiple protein complexes that are involved
in various biological processes. Our findings of Abraxas phosphorylation-mediated
BRCA1 dimerization at DNA damage sites provides key mechanistic insights into its
efficient accumulation to damaged chromatin to repair DNA. However, several
important questions still remain to be addressed to understand how BRCA1
dimerization plays an essential role in its tumor suppressor function. Is BRCA1
dimerization important for efficient DNA repair function of BRCA1 and thereby
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Figure 18. Proposed model showing IR-induced ATM-dependent
phosphorylation of Abraxas induces BRCA1 dimerization at sites of DNA
damage for efficient BRCA1 accumulation to damaged chromatin. Abraxas Cterminal S404 is phosphorylated in DNA damage dependent manner that promotes
stable dimerization of BRCA1 BRCT-Abraxas complex at the sites of damage. S404
phosphorylation is essential for efficient BRCA1 accumulation to damaged
chromatin and germline mutations in the BRCA1-BRCT dimerization interface
disrupts the dimer formation.
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maintaining genome stability? Although I have examined that germline mutations in
the BRCT dimerization interface disrupt dimer formation, future study is needed to
further examine whether these germline mutations impair BRCA1’s role in DNA
repair or DNA damage signaling. In addition, whether the dimerization is essential
for accumulation of BRCA1 to damaged chromatin and thereby triggering efficient
DDR signaling demands further investigation. Another important question that needs
to be addressed is identification of the kinase that directly phosphorylates S404 in
response to DNA damage. Our findings indicate S404 is phosphorylated ATMdependent manner. However, proteomic analysis identified more than 700 proteins,
including many downstream kinases, as substrates for ATM and ATR (18).
Identification of the kinase responsible for S404 phosphorylation will, therefore,
broaden our understanding of the damage-induced phosphorylation signaling
cascade at the damage site. Answers to these questions will shed light into how
Abraxas phosphorylation-mediated dimerization of BRCA1 plays an essential role at
the DSB sites to exert its function in the DDR signaling and thereby functioning as a
‘master regulator’ for maintaining genomic integrity.
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CHAPTER 3
INTRODUCTION: ROLE OF LYSINE11-LINKAGE-SPECIFIC UBIQUITINATION IN
THE DNA DAMAGE RESPONSE PATHWAY
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3.1 Introduction
Ubiquitin is a 76 amino acid long polypeptide that is highly conserved among
eukaryotic kingdom identified initially as ATP-dependent protein degradation
component in reticulocytes (100-102). However, recent years have witnessed an
unprecedented growth in our understanding of the non-proteolytic functions of
ubiquitination in cellular signaling (103). Covalent conjugation of ubiquitin molecule
to substrate proteins governs a wide range of cellular processes including protein
degradation, transcription, cell cycle progression, immune response, and receptor
trafficking as well as viral infection. Protein ubiquitination is a three-step enzymatic
process mediated by E1 activating enzyme, E2 conjugating enzyme and E3 ligase
enzyme (104). Ubiquitin is activated by an E1 activating enzyme in an ATPdependent manner forming thioester bond between the C-terminal carboxyl group of
Gly residue of ubiquitin and the active cysteine residue of the E1 enzyme (105). In
the following step, the ubiquitin is transferred to the cysteine residue of the cognate
E2 enzyme (106) and subsequently transferred to the ε-amino group of a lysine
residue of the substrate forming an isopeptide linkage in presence of an E3 ligase
(107). Monoubiquitination of substrates in one or more than one lysine residues
(multi-mono ubiquitination) is highly abundant in eukaryotic cells suggesting the
functional significance of this modification in cellular signaling (108). For example,
(multi) mono-ubiquitination of cell surface receptor proteins plays a crucial role in
endocytosis and subsequent degradation of these receptors in lysosomes or
recycling back to the cell surface (109).
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Figure 19: Schematic of ubiquitin system. Ubiquitination is an enzymatic
process that involves covalent attachment of ubiquitin to target protein catalyzed
by E1 activating, E2 conjugating and E3 ligase enzymes. These enzymes not
only transfer ubiquitin to protein substrates at single or multiple lysine residues,
but also promote the formation of long polyubiquitin chains through one of seven
lysine residues of ubiquitin as shown here in blue forming polyubiquitin chain of
distinct linkages.
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Interestingly, unlike phosphorylation, ubiquitin machinery can also add further
ubiquitin molecules through one of the seven lysine residues in substrate-conjugated
ubiquitin molecule synthesizing polyubiquitin chain of distinct lineages forming
polyubiquitin chain of distinct linkages (110, 111). In addition, recent findings indicate
the existence of an eighth kind of ubiquitin chain formed through the N-terminus of
ubiquitin, also known as ‘Met1-linked’ or linear chains, demonstrating the magnitude
of complexity of the ‘ubiquitin code’ (112). Proteomic approaches have shown the
existence of all seven lysine residue-linked as well as Met1-linked linear
ubiquitination in cells (108, 113-115). Since different ubiquitin chains adopt a distinct
structure that can be recognized by specific ubiquitin-binding domain (UBD)
containing proteins, ubiquitin chain with different length and topology trigger vastly
different molecular signals in vivo (116, 117). Chain specificity is an intrinsic property
of E2 enzymes; and E3 ligases interact with different E2 enzymes generating
different linkage-specific ubiquitin chains on substrate proteins (106, 118). In
eukaryotes, there are approximately 35 E2s and more than 500 E3 enzymes have
been reported to date. Given the vast number of different E2-E3 combinations, this
provides an additional layer of regulation for assembly of linkage-specific
ubiquitination. Furthermore, similar to other post-translational modifications, cellular
ubiquitination is also reversible process, in which enzymes known as
deubiquitinases or DUBs cleave the polyubiquitin chain on substrates, thereby
recycling and maintain free ubiquitin pool in the cell. There are around 100 DUB
enzymes encoded by the human genome that oppose the function of E3 ligases and
thereby regulating the ubiquitin signaling in cells (89). Therefore, precise balance
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and coordination among ‘writer’, ‘reader’ and ‘eraser’ for the ‘ubiquitin code’
propagates specific cellular signaling in vivo essential for cellular homeostasis.
3.1.1 Linkage-specific ubiquitination:
Among different lysine residue-linked ubiquitination, canonical Lys48-linked
ubiquitination was first identified and assumed to be the only linkage type targeting
proteins for degradation (119, 120). Over the following years, Lys63-linked
ubiquitination was identified as a non-proteolytic signal involved in DNA repair in
yeast Saccharomyces cerevisiae (121). Since then Lys63-linked ubiquitination has
been extensively studied in the DNA damage response pathway as well as other
non-proteolytic pathways including vesicular traffic, endocytosis, and NF-kB
pathways (122-125). However, our knowledge of the role of other linkage-specific
ubiquitination in cellular signaling pathways remained limited. One of the major
challenges in the field of linkage-specific ubiquitination is the detection of different
lysine residue-linked ubiquitin conjugation in cells due to varying degree of chain
abundance and rapid turnover of ubiquitin chains by different DUB enzymes.
Nonetheless, advancement in mass-spectrometry-based proteomic approaches
such as Absolute QUantitative Analysis (AQUA) as well as Protein Standard
Absolute Quantification (PSAQ), paves the way to gain further insights into the
unexplored world of different linkage-specific ubiquitination in cells (108, 111, 113,
114, 126-129). Although different groups have reported a varying abundance of
linkage-specific ubiquitin chains, findings from these studies suggest the presence of
all different chain types in yeast and mammalian cells.
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3.1.2 Linkage-specific polyubiquitination in the DNA damage response
pathway:
Although mass-spec analysis identified the existence of all seven lysine
residue-linked ubiquitination in cells, the functional significance of these different
chain types in various cellular signaling pathways in cells still remains to be
determined. Given the heterogeneity of ubiquitin code and complexity of the DNA
damage response signaling, it is not tempting to speculate that many of these
ubiquitin chains exist at the damaged chromatin. Indeed seminal studies done by
different groups had conclusively shown that Lys63-linked ubiquitin conjugation is
predominant at DNA damage sites modifying histone proteins at damaged chromatin
and regulating downstream DDR factor recruitment such as 53BP1 and components
of the BRCA1-A complex (37-39, 41, 43-45). Along with Lys63-linked ubiquitination,
several biochemical studies and mass-spec analysis identified existence of other Lys
residue-linked ubiquitination including Lys6, 27, 29, 33 and 48 at damaged
chromatin and the abundance of this ubiquitin chains can alter dramatically in
response to DNA damage. Together these findings indicate that ubiquitin signaling
at the damage sites is much more complex than anticipated before.
3.1.3 Lys63-linked ubiquitin chain:
DNA damage-induced Lys63-linked ubiquitin conjugation is the most well
characterized linkage-specific ubiquitination involved in the DNA damage response
pathway. In one of the seminal articles, Finley and colleagues first reported
existence of the Lys63-linked ubiquitin conjugates in yeast Saccharomyces
cerevisiae (121). Although yeast strains carrying K63R mutant ubiquitin were
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proficient in growth and efficient in turning over of cellular proteins, K63R mutation
conferred hypersensitivity to DNA damaging agents such as methyl
methanesulfonate (MMS), UV, X-rays providing key evidence that nonproteolytic
Lys63-linked ubiquitination is involved in the DDR signaling pathway. Subsequent
studies identified Ubc13/Mms2 heterodimer assembles Lys63-linked polyubiquitin
chain in vitro and in yeast (122, 130). To identify the E3 ubiquitin ligase involved in
the Lys63-linked ubiquitination, Plans et al performed yeast two-hybrid screening
using Ubc13 (also known as Ube2N) as bait and identified human Ring finger protein
8 (RNF8) as an E3 ligase that interacts and co-localizes with human Ubc13 in cells.
Further analysis demonstrated that RNF8 functions as a self-ubiquitin ligase that is
polyubiquitinated in Lys63-linked manner mediated by Ubc13 (131).
Although these early findings provided the key insights into the enzymatic
machinery catalyzing non-proteolytic Lys63-linked ubiquitination, the functional role
of this ubiquitination in the DDR signaling was still missing until 2007 when
independent studies demonstrated Lys63-linked polyubiquitin conjugate enrichment
at damaged chromatin by elegant biochemical approaches (37-39, 41). These
studies have conclusively shown that a phosphorylation-dependent ubiquitin
signaling cascade at the DSB sites orchestrates the DNA damage response
signaling by functioning as a molecular scaffold to recruit downstream DDR factors.
Upon DNA damage, ATM-mediated phosphorylation of adaptor protein MDC1
recruits RNF8 to DSBs flanking chromatin. Once recruited, RNF8, in association with
Ubc13, initiates non-proteolytic Lys63-linked ubiquitination of histones H2A and
H2A.X. The assembly of the Ubc13-RNF8 complex is further facilitated by another
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E3 ligase, HERC2, which is phosphorylated by ATM upon DNA damage and
interacts with RNF8 FHA domain (40). Later studies demonstrated that initial Lys63linked ubiquitin polymer generated by Ubc13-RNF8 enzymes is recognized by
ubiquitin binding domain of another E3 ligase, RNF168 that functions in concert with
Ubc13 and amplifies the Lys63-linked ubiquitin chain on H2A and H2A.X generating
polyubiquitin chain of Lys63 lineage (43-45). Ubc13-RNF8-RNF168-mediated
Lys63-linked ubiquitination of core histones and other unidentified non-histone
proteins at damaged chromosomes is crucial to transduce the DDR signal by
recruiting the DDR mediator proteins, BRCA1 and 53BP1 to DSB sites. As shown by
our lab and several other groups, Lys63-linked polyubiquitin conjugates at DSB sites
is recognized by ubiquitin interacting motif (UIM) of Rap80 protein that recruits
Abraxas and subsequently the entire BRCA1-A complex, which includes Abraxas,
Rap80, NBA1, BRE and BRCC36 (41, 47, 49, 51, 132, 133). Recruitment of these
factors to DNA damage sites is essential for efficient DNA repair and checkpoint
signaling indicating the functional significance of these enzymes in the DDR
pathway. Although these studies showed core histone proteins, H2A and H2A.X are
modified by Lys63-linked ubiquitination; it is likely that other non-histone proteins at
damaged chromatin are also modified by this modification. Identification and
characterization of these proteins will broaden our understanding of the complexity
of the DDR signaling.
In addition to BRCA1, Lys63-linked ubiquitination on nucleosome also recruits
another mediator protein 53BP1 to the sites of DNA damage. Earlier studies have
demonstrated that 53BP1 localization to damaged chromatin is mediated by
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recognition of dimethylated histone H4K20 (H4K20me2) by tandem Tudor domain of
53BP1 (134). However, impaired recruitment of 53BP1 in RNF8 and RNF168
depleted cells raised the possibility that Ubc13-RNF168 catalyzed Lys63-linked
ubiquitination at damaged chromatin may also promote its recruitment to IR-induced
foci (37-39, 43). Consistent with this idea, recent experimental evidence by Durocher
group have shown that in addition to its Tudor domain, 53BP1 also harbors a Cterminal extension, termed as ubiquitination-dependent recruitment (UDR) motif that
specifically recognizes ubiquitinated histone H2A on lys15 (H2AK15ub) (135).
Together these findings propose a model of 53BP1 recruitment to DNA damage
sites as a bivalent reader recognizing both H4K20me2 and Ubc13-RNF8-RNF168
mediated H2AK15ub.
Although the seminal studies provided key evidence of histones H2A and
H2A.X as major substrates for Lys63-linked ubiquitination, the full-spectrum of
substrates modified by Lys63-linked ubiquitination still remained largely unknown. In
this light, it is of interest that a recent study identified H1-type linker histone as a key
substrate modified by the Ubc13-RNF8 complex in DNA damage-dependent manner
forming Lys63-linked ubiquitin chain. The lys63-linked chain functions as an
interacting module for RNF168 through its N-terminal ubiquitin-dependent DSB
recruitment module 1 (UDM1). Once recruited, the Ubc13-RNF8-RNF168 enzymatic
machinery then catalyzes Lys63-linked ubiquitination of core histone proteins.
Consistently, depletion of linker histone impairs Lys63-linked ubiquitin conjugation
and accumulation of DDR factors at damage sites including BRCA1. These findings
propose a model where Ubc13-RNF8 complex and RNF168 function as writer and
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reader, respectively of the Lys63 ubiquitinated linker histone H1 protein expanding
the ‘histone code’ in the DNA damage response pathway (136).
3.1.4 Lys6-linked ubiquitin chain:
In the DNA damage response pathway, Lys6-linked ubiquitination was initially
identified as polyubiquitin chain catalyzed by heterodimeric BRCA1/BARD1 E3
ubiquitin ligase complex. Both in vitro and in vivo analysis have shown that
BRCA1/BARD1 ligase complex catalyzes autoubiquitination of BRCA1 in Lys6linked polyubiquitin chain that is recognized but not degraded by the 26S
proteasome (81-84). In addition to BRCA1 autoubiquitination, BRCA1/BRAD1 ligase
complex has been shown to ubiquitinates RPB8, a subunit of RNA polymerase
holoenzyme, upon UV-induced DNA damage. While retaining its function as a
subunit of RNA polymerase complex, the Lys6-linked polyubiquitin-resistant RPB8
mutant showed UV hypersensitivity in cells emphasizing the role of Lys6-linked
ubiquitination in the DDR pathway (137). These findings have been validated further
by recent global profiling of the ubiquitin species in cells showing that enrichment of
Lys6-linked polyubiquitin conjugates after UV treatment but not irradiation (IR)induced DNA damages (138). BRCA1 has been shown to localize to UV-induced
foci and functions in a DNA replication-dependent manner to facilitate postreplicative repair (139).
In addition to BRCA/BARD1, another RING domain E3 ligase, RNF8, has
been shown to catalyze Lys6-linked ubiquitination of Nbs1, a component of the MRN
(MRE11-Rad50-Nbs1) protein complex that senses the DNA double-strand breaks.
The E2 conjugating enzyme UbcH5c and E3 ligase RNF8-mediated Lys6-linked
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ubiquitination of Nbs1 is essential for efficient recruitment of Nbs1 to damaged
chromatin to promote HR repair (140). Consistent with these findings massspectrometry analysis have confirmed no significant enrichment of Lys6-linked
polyubiquitin conjugates upon treatment with proteasomal inhibitor MG132 indicating
unlike Lys48-linked ubiquitination, Lys6 polyubiquitin chain is involved in nonproteolytic functions in cells (141, 142).
3.1.5 Lys27-linked ubiquitin chain:
Lys27-linked ubiquitination has emerged recently as another ‘atypical
ubiquitination’ involved in the DNA damage response pathway. In their recent
findings Penengo and colleagues have analyzed different lysine residue-linked
ubiquitination in cells overexpressing RING E3 ligase, RNF168, which has been
shown previously to catalyze Lys63-linked ubiquitination at the damage sites (43-45,
143). Selected reaction-monitoring mass spectrometry (SRM) analysis revealed that
overexpression of RNF168 leads to Lys27-linked polyubiquitin conjugation in cells.
In addition their findings indicate histone proteins, H2A and H2A.X, were modified by
RNF168-mediated Lys27-linked polyubiquitination. Furthermore, Lys27-linked
chromatin ubiquitination is essential for efficient recruitment of DDR mediators such
as BRCA1, 53BP1, Rap80, RNF168, RNF169 to DSB sites and therefore is required
for optimal activation of the DDR signaling (56). Taken together, these findings
revealed new roles of linkage-specific ubiquitination induced by genotoxic stress
providing insights into the complexity of ‘ubiquitin code’ at the DNA damage site.
3.1.6 Lys29 and Lys33-linked ubiquitin chain:
While functions of Lys29-and Lys33-linked ubiquitination in DNA damage
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response still remain largely elusive, findings from recent studies provide evidence
of these linkage-specific ubiquitination in various other signaling pathways such as
Wnt/β-catenin signaling and protein trafficking, respectively (110, 111). Both these
modifications have been shown to be enriched upon treating the cells with
proteasomal inhibitor MG132 suggesting proteolytic functions of these chain types in
cells (113, 142). Interestingly recent quantitative proteomic analysis of global
ubiquitination profile in mammalian cells by Elledge and colleagues showed a
marked increase (about 2 fold) in endogenous Lys33-linked ubiquitination upon UVinduced but not IR-induced DNA damages (138). Although functional significance of
these preliminary findings demand further investigation, given the complexity of the
DDR signaling and ‘ubiquitin code’, it is tempting to speculate that these
modifications play potential roles in the DNA damage response pathway.
3.1.7 Lys48-linked ubiquitin chain:
Although degradation-linked Lys48 ubiquitination has been extensively
studied in various cellular signaling, its role is obscured in the DDR pathway. Since
DDR factor retention at the sites of DNA damage needs to be tightly regulated, it is
likely that many of the DDR factors are modified with Lys48 ubiquitin chain to ensure
removal of these factors from sites of DNA damage in a timely manner. In one of the
earliest studies using Xenopus egg extract coupled to tandem Mass-spectrometry,
Funabiki and colleagues showed that among different DDR factors, Ku80, a crucial
factors in the NHEJ repair pathway, is modified with Lys48-linked ubiquitin chain
upon binding to DBS containing DNA by Skp1–Cul1–F-box (SCF) E3 ligase
complex. Strikingly, although proteasome targets for lys48 ubiquitin decorated Ku80
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once it is released from DSB, the proteasome activity is not required for Ku80
removal from DSBs (144, 145). Another study by Shi et al showed that MDC1 is
heavily ubiquitinated with the Lys48-linked chain in DNA damage-dependent manner
and subsequently degraded by the proteasome that is essential for disassembly of
MDC1 protein from the sites of DNA damage (146). Similar to MDC1, BRCA1 has
also been shown to be ubiquitinated and degraded following a high dose of
irradiation (IR)-induced DNA damage, independent of its autoubiquitination E3 ligase
activity and is required for IR-induced apoptosis (147, 148). More recently, RNF8 E3
ligase, which has been identified as an E3 ligase catalyzing Lys63-linked
ubiquitination in concert with the Ubc13 E2 enzyme at damaged chromatin, has
shown to function with another E2 conjugating enzyme, UbcH8, to catalyze Lys48linked ubiquitin chain at the damage sites. RNF8-mediated Lys48-linked
ubiquitination of Ku80 regulates its turnover at the sites of DNA damage regulating
NHEJ-mediated DNA repair (57, 58). Kinetic analysis of Lys48 and Ly63-linked
ubiquitination at the sites of DNA damage using linkage-specific antibody showed
that Lys48-linked ubiquitin chain is assembled at the DSBs immediately after DNA
damage, while Lys63-linked ubiquitin conjugation occurs at much slower rate at the
damaged chromatin facilitating coordinated recruitment of DDR factors (57, 149).
These observations suggest that Lys48-linked ubiquitin conjugation and proteasome
are the essential elements of the DDR signaling that regulate orchestration of DDR
factors.
3.1.8 Lys11-linked ubiquitination:
Lys11-linked ubiquitination was first identified as novel ubiquitin chain type
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catalyzed by Ube2S (also known as E2-EPF) in 1996 (150). Later studies identified
another E2 conjugating enzyme Ube2C (also known as UbcH10) that along with
Ube2S catalyze Lys11-linked ubiquitin chain on substrates in presence of APC/C E3
ubiquitin ligase (151-155). APC/C is a large multisubunit E3 ligase complex that in
association with Ube2S and Ube2C modifies mitotic and G1 phase cell cycle
proteins including CyclinB1 and securin, with Lys11-linked ubiquitin chain and target
proteasomal degradation (156). In recent years, Ube2S/Ube2C and APC/Cmediated Lys11-linked ubiquitin chain assembly has emerged as a major regulatory
player in proper cell cycle progression. Importantly, recent studies identified an OUT
family deubiquitinase (DUB), Cezanne (also known as OTUD7B), which
preferentially cleaves Lys11 ubiquitin chain (157, 158). Interestingly, although a
proteomic study identified Lys11-linked ubiquitination as one of most abundant
ubiquitin chain types in cells (114), the role of Lys11-linked ubiquitination in the DDR
pathway still remains to be elucidated.
3.1.9 Objective:
Chromatin modification at DNA damage sites constitutes an immediate
component of the cellular response to DNA damage for signaling and repair. While
proteomic analysis of global ubiquitination profiling revealed assembly of all seven
lysine residue-linked ubiquitination in a varying degree of abundance in both yeast
and mammalian cells (113, 114, 159), function and characterization of non Lys63linked ubiquitin conjugation at the DSB sites still demands further investigation.
Since the DNA damage response signaling encompasses a vast number of
molecules, depending on the type of DNA lesions experienced by the cell, it is not
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surprising that DDR factors are modified with non Lys63-linked ubiquitin chains as
well to regulate the DDR signaling and facilitate efficient repair. Although recent
findings by above-mentioned studies showed promising evidence of the existence of
different types of ubiquitin linkages in UV- and IR-induced DNA damage sites, much
is still missing for understanding the role of linkage-specific ubiquitin chains in the
regulation of DNA damage response and repair. Therefore, in this study, I aim to
explore existence and functional significance of non-lys63-linked ubiquitin
conjugation at the DNA damage sites. Findings from this study will broaden our
understanding of the complexity of ubiquitin signaling at the damage sites.
3.2. Materials and Methods
3.2.1 Cell Culture, Transfection, Antibodies and Reagents
U2OS and HEK293T cells were grown in McCoy’s 5A and DMEM medium
respectively with 10% fetal bovine serum (FBS) and maintained at 37°C with 5%
CO2. For generation of stable knockdown cell lines, cells were infected with
retrovirus containing shRNAs against Ube2S, Ube2C or CDH1 followed by selection
with puromycin (0.8 µg/ml) or blasticidin (9 µg/ml) according to the selection marker
of the construct. For generation of Ube2S/Ube2C double knockdown cell line,
Ube2S-knockdown cells were further infected with retrovirus containing Ube2C
shRNA followed by selection with blasticidin. For transient transfection, cells were
transfected with PEI (polyethylenimine) or Lipofectamine 2000 (Invitrogen).
Antibodies used in this study are listed in Table 1. Other regents used are listed in
Table 2.
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3.2.2 Plasmids, shRNAs and siRNAs
Retroviral constructs expressing GFP-Ube2S, GFP-Ube2C, Flag-RNF8 were
generated using MSCV vector. Flag-tagged histone plasmids were kindly provided
by Dr. Yuzuru Shiio (160), University of Texas Health Science Center at San
Antonio. HA-tagged WT and K0 ubiquitin plasmids (pRK5-HA-ubiquitin) were
obtained from Addgene (161) and lysine-only ubiquitin mutants were generated by
site-directed mutagenesis. His-Biotin (HBT)-WT ubiquitin (pQCXIP HB-Ubiquitin)
was used to generate His-biotin-K11 ubiquitin mutant through site-directed
mutagenesis. The shRNAs and siRNAs used in this study are listed in Table 3. GFPtagged siRNA1-resistant Ube2S clone was generated by inserting three nucleotide
mismatches underlined (TCTTCCCAAATGAGG) into Ube2S sequence by sitedirected mutagenesis using the primers described in the Table for resources and
subsequently recombining into pDEST-MSCV-GFP vector.
3.2.3 Immunofluorescence
Immunofluorescence was carried out as described previously (55). Briefly,
cells were fixed with 2% formaldehyde for 10 min at room temperature,
permeabilized with 0.5% Triton X-100 solution (25 mM HEPES pH 7.4, 50 mM NaCl,
1 mM EDTA, 3 mM MgCl2, 300 mM Sucrose, 0.5% triton-X) at 4°C for 5 min and
incubated with primary antibodies at 37°C for 1 hr. Appropriate secondary antibodies
conjugated with Alexa 488-conjugated (green; Invitrogen) and Alexa 555-conjugated
(red; Invitrogen) were used. For endogenous Ube2S immunostaining following laser
micro-irradiation, cells were pre-extracted with ice-cold pre-extraction buffer (10 mM
PIPES, pH 7, 100 mM NaCl, 300 mM Sucrose, 3 mM MgCl2, 0.2% Triton-X100) for
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5 min at room temperature before fixation and permeabilization. Images were
obtained by Nikon confocal microscope.
3.2.4 Cell Lysis and Immunoprecipitation
Cells were lysed in NETN buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1
mM EDTA, 0.5% Nonidet P-40, 1 mM DTT) with protease inhibitors, 1 mM PMSF,1
mM NaF, 1 mM Na3VO4 and 20 mM N-Ethylmaleimide (NEM) (freshly prepared). For
Flag immunoprecipitation, Flag beads (98) were added to cell lysates and incubated
overnight with gentle agitation at 4°C. The beads were washed four times with NETN
lysis buffer before elution with 2X sample loading buffer. For Flagimmunoprecipitation under denaturing condition, cells were harvested and washed
with PBS, cell pellets were resuspended in denaturing lysis buffer (20 mM Tris, pH
7.4, 50 mM NaCl, 0.5% NP-40, 0.5% sodium deoxycholate, 0.5% SDS, 1 mM EDTA,
20 mM N-Ethylmaleimide (NEM) and protease inhibitors). The lysates were
sonicated, centrifuged and immunoprecipitated with Flag-beads overnight at 4°C
with gentle agitation. The beads were then washed with denaturing lysis buffer four
times before elution with 2X sample buffer.
3.2.5 Chromatin fractionation
Chromatin fractionation was carries out as described previously (87). The
chromatin fraction pellet was resuspended in NETN lysis buffer containing 20 mM
NEM and protease inhibitors. After sonication and centrifugation at 15000 rpm for 10
min, the supernatant was collected as chromatin fraction and protein concentration
was measured by Bradford assay. 10 µg of total chromatin fraction protein was used
for western blot analysis.
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3.2.6 Laser-induced DNA Damage and Live Cell Imaging
U2OS cells were cultured in glass-bottomed dish or 8-well chambers (Mattek
Cultureware). BrdU (BD Biosciences) was added to medium with a final
concentration 10 µM 24 hour prior to laser irradiation. Nikon TE2000 inverted
microscope coupled with a MicroPoint laser system with a UV laser (364 nm) and
60X water lens was used with laser energy output set to 20-30% and number of
pulses set to five (total of 335 ms). Following laser ablation, cells were either fixed
for immunostaining at indicated time points or monitored by live cell imaging with
images captured at 30 seconds intervals. Live-cell imaging was taken and analyzed
with Metamorph software.
3.2.7 Clonogenic survival assay
The assay was performed as described previously (87). Briefly, U2OS cells
were plated at low density and treated with 4 or 6 Gy IR (or left untreated). The cells
were then incubated at 370C for two weeks to form colonies. Colonies were fixed
and stained with 2% methylene blue and 50% ethanol. Colonies with 50 or more
cells were counted as positive.
3.2.8 Nascent transcript detection at DNA damage sites
U2OS cells were transfected with control or Ube2S/Ube2C siRNAs. 48 hr
post-transfection, cells were subjected to laser-microirradiation. 5-ethynyl uridine (5EU) was added to the media immediately after laser treatment to a final
concentration of 1 mM followed by incubation at 370C for 1 hr. Cells were then fixed,
permeabilized and incorporation of 5-EU was detected by Click-iT RNA imaging kit
(Invitrogen) following manufacturer’s instruction and IF staining of γH2AX was
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carried out after Click-it reaction. Relative 5-EU intensity along the laser track was
quantified using Nikon Elements software and normalized to γH2A.X mean intensity
along the same region.
3.2.9 Histone acid extraction
U2OS cells harvested and washed with 1X PBS were resuspended in freshly
prepared cytosolic extraction buffer (10 mM HEPES pH 7.9, 10 mM KCl, 1.5 mM
MgCl2, 0.34 M sucrose, 10% glycerol, 5 mM NaF, 1 mM Na3VO4 , 1 mM dithiothreitol
(DTT), 0.5% Triton-X, 20 mM NEM) with protease inhibitors at a concentration of 107
cells/ml and incubated on ice for 10 min followed by centrifugation at 4000 rpm for 5
min at 4°C. Cell pellet was washed once with cytosolic extraction buffer and then
resuspended in 0.25N HCl at a cell density of 4X107/ml and incubated at 4°C for 3 hr
followed by centrifugation at 12,000 rpm for 5 min at 4°C. The supernatant was then
collected and 1 ml ice-cold acetone was added for overnight at -20°C. Following
centrifugation at 12,000 rpm for 5 min at 4°C, the pellet was rinsed with acetone
once, air-dried at room temperature, and dissolved in 25 µl 50 mM Tris, pH 7.4
buffer. 5-10 µg of acid-extracted histones was used for western blot analysis.
3.2.10 Streptavidin beads pull-down
HeLa cells stably expressing His-Biotin-K11 ubiquitin were grown in media
supplemented with 2 µg/ml Biotin for 36 hr before treatment with 10 Gy IR. After
irradiation, cells were incubated at 37°C for 30 min, then lysed in denaturing buffer
(8M Urea, 300 mM NaCl, 0.5% NP-40, 50 mM Na2HPO4, 50 mM Tris, pH 8, 1 mM
PMSF, 20 mM NEM). Lysates were sonicated and pull-down with Streptavidin beads
was carried out overnight at room temperature. Beads were washed 4 times with
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denaturing buffer and bound proteins were eluted with sample buffer and analyzed
by SDS-PAGE and western blot using ubH2A antibody.
2.2.11 In vitro ubiquitination assay
For in vitro ubiquitination assay, 1 µg histone H2A (New England Biolabs) or 2
µg mononucleosome or 1 µg H2A/H2B dimer was incubated with 50 ng E1 (Boston
Biochem), 50 or 100 ng of each of Ube2S and Ube2C (Abcam), 2 µg ubiquitin
(Boston Biochem) and purified Flag-RNF8 in 20 µl reaction mixture buffer (50 mM
Tris, 5 mM KCl, 5 mM MgCl2, 0.5 mM DTT, 200 mM Creatine phosphate
(Calbiochem), 2 µg/µl Creatine Phosphokinase (Calbiochem), 2 mM ATP(New
England Biolabs) at 32°C for 2 hr. The reaction was stopped by addition of sample
buffer and resolved by SDS-PAGE. Flag-RNF8 was purified from HEK293T cells
expressing Flag-tagged RNF8. Flag immunoprecipitation was carried out by
incubating Flag-beads with cell lysates overnight at 4°C with gentle agitation. The
beads were then washed by NETN buffer followed by elution with 3X Flag peptide
(98). For RNF8 autoubiquitination assay, Flag-RNF8 was incubated with purified
ubiquitin (2 µg), E1 activating enzyme (50 ng), 50 or 100 ng of each of Ube2S and
Ube2C in the reaction mixture buffer at 32°C for 2 hr. For recombinant GST-RNF8 in
vitro autoubiquitination assay, 500-1000 ng of purified GST-RNF8 was used.
Reaction was stopped by addition of 2X sample loading buffer and analyzed by
western blot with FK2 antibody.
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Table 1: List of Antibodies:
Antibody

Company/Source

Catalogue number

BRCA1

Santa Cruz

Cat#sc-6954

γ-tubulin

Sigma Aldrich

Cat#T3559

HA

Cell Signaling

Cat#C29F4

Ube2S

Cell Signaling

Cat#9630

Ube2C

Sigma Aldrich

Cat#WH0011065M1

Flag

Sigma Aldrich

Cat#F7425

H2A

Abcam

Cat#Ab13923

H2AX

Abcam

Cat#Ab11175

H3

Abcam

Cat#ab1791

H2B

Abcam

Cat#ab1790

phospho H3

Millipore

Cat#06-570

53BP1

Upstate

Cat#05-726

γ-H2A.X

Upstate

Cat#05-636

γ-H2A.X

Millipore

Cat#07-164

ubH2A

Millipore

Cat#05-678 (lot 22424)

GFP

Invitrogen

Cat#A11122

FK2

Biomol

Cat#PW8810

Cyclin B1

Santa Cruz

Cat#SC245

ATM

Cell Signaling

Cat#2873S

ATR

SantaCruz

Cat#sc-1887

Ubc13

Zymed Laboratories

Cat#37-1100

Rap80

Bethyl

Cat#A300-763A

Rpb1

Santa Cruz

Cat#sc-899

PCNA

Santa Cruz

Cat#sc-56

OTUD7B

Santa Cruz

Cat#sc-514402

Abraxas

Wang et al., 2007

N/A

Cdh1

NeoMarkers

Cat# MS-1116-P0

MDC1

Stuart et al., 2003

N/A
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Table 2: List of chemicals, recombinant proteins and reagents:
Chemicals (Inhibitors), Purified protein,

Company

Catalogue number

reagents

MG132

Thermo Scientific

Cat#NC9819784

NEM

Thermo Scientific

Cat#128-53-0

proTAME

Boston Biochem

Cat#I-440

Purified GST-RNF8

Ubiquigent

Cat#63-0021-025

Purified Ube2S

Abcam

Cat#ab87756

Purified Ube2C

Abcam

Cat#ab151891

Recombinant Human Mononucleosome

EpiCypher

Cat#16-0009

Recombinant Human H2A/H2B dimer

EpiCypher

Cat#15-0311

Recombinant Human histone H2A

NEB

Cat#M2502S
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Table 3: List of shRNA and siRNA sequences:
Ube2S shRNA - TGGAGGTCTGTTCCGCATG
Ube2C shRNA - GGAGCAGCTGGAACAGTAT
Cdh1 shRNA - GGGAAGAAGCTGTCCATGT
Ube2S siRNAs
(siRNA1-GGUCUUUCCCAACGAGGAG,
siRNA2-CAAGGAGGUGACGACACUG,
siRNA3-CAUGCUGGCGAGCGCGAUA)
Ube2C siRNAs
(siRNA1-CCUACUCAAAGCAGGUCAC,
siRNA2-GUGUCGUCUUUUUAAUUUU)
ATM siRNAs
(siRNA1-GCGCAGTGTAGCTACTTCTTCTATT,
siRNA2- GGGCCTTTGTTCTTCGAGACGTTAT,
siRNA3-GCAACATTTGCCTATATCAGCAATT)
ATR siRNAs

Invitrogen

MDC1 siRNAs

Invitrogen
(Stealth siRNA)

RNF8 siRNAs
(siRNA1-GGGUUUGGAGAUAGCCCAAGGAGAA,
siRNA2-GCAGCAAGAAGGACUUUGAAGCAAU,
siRNA3-GGAGAAUGCGGA- GUAUGAAUAUGAA)
Ubc13 siRNAs
(siRNA1-UUCUGGAAGGAAUAGUUCAAGUUUA,
siRNA2-UUCCCAACUUGUCUACAUUAGGAUG,
siRNA3-AUUGGGAGCACUUAACAAGGCCUGG)
Cezanne (OTUD7B) siRNAs
(siRNA1 – AGGUCUCUCUCUAUGAAGC,
siRNA2 – CUUCUGUGUAUACCAGCCC)
H2AX siRNAs

Invitrogen
(Stealth siRNAs

Apc2 siRNAs
(siRNA1 – GAGAUGAUCCAGCGUCUGUUU,
siRNA2 –GACAUCAUCACCCUCUAUAUU)

Dhamrmacon

Invitrogen

Invitrogen
(Stealth siRNA)

Invitrogen
(Stealth siRNA)

HSS100876,
HSS100877,
HSS100878
HSS114445,
HSS114446,
HSS114447

Invitrogen
(Stealth siRNAs

Invitrogen

Invitrogen stealth
siRNAs
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HSS142372,
HSS142373,
HSS142374

3.3. Results
3.3.1 Analysis of linkage-specific ubiquitin mutant conjugation at DNA damage
sites
As described in section 3.1, all seven lysine residues in ubiquitin molecule
can serve as conjugate sites for additional ubiquitin molecules forming polyubiquitin
chain of distinct lineages. To test whether different linkage-specific ubiquitin
conjugation occurs at the site, GFP-tagged single lysine only ubiquitin mutants (K6-,
K11-, K27-, K29-, K33-, K48- and K63-), in which all lysine residues except one were
mutated to arginine, as well as a lysine-less mutant with all lysine residues mutated
(K0) were generated (Figure 20A). Stable U2OS cells expressing GFP-tagged WT or
lysine only and K0 ubiquitin mutants were generated by infecting WT U2OS cells
with retroviral constructs expressing WT or abovementioned ubiquitin mutants.
Western blot analysis confirmed GFP-WT or mutant Ub was expressed at a similar
level and was able to form polyubiquitin conjugates indicated by higher molecular
weight bands in the western blot with GFP antibody. (Figure 20B). To test
conjugation of different lysine only ubiquitin mutants at the DNA damage sites, a
laser ablation system equipped with live-cell imaging was utilized to induce DNA
damage at a particular region in the nucleus and conjugation of different ubiquitin
mutants as the damage sites were monitored by time-lapse microscopy. As shown in
Figure 21A, GFP-WT and GFP Lys63 Ub were deposited at laser-induced DNA
damage tracks immediately after laser treatment, in consistent with an established
role of ubiquitin conjugation occurring at DNA damage
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Figure 20 :Generation of lysine only ubiquitin mutants. A Schematic
representation of different lysine only ubiquitin mutants.
linkages. B. Western blot analysis of cell lysates from U2OS cells stably
overexpressing GFP-tagged WT or lysine only ubiquitin mutants. Expression of GFPubiquitin was detected by GFP antibody. (*) indicates a non-specific band used as
loading control.
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sites (37-39, 41, 43-45, 162). Interestingly, GFP-K11 Ub was observed accumulating
at laser-irradiated tracks robustly with similar kinetics as that of GFP-K63 Ub or K48
Ub (Figure 21A and B). Compared to WT, GFP-K63, -K48, and -K11; accumulation
of GFP-K6, K27, K29, K33, and K0 Ub to laser tracks were mild during the time
frame of imaging. These findings suggest that mono-ubiquitination or polyubiquitin
conjugation with linkages other than Lys11, 48 and 63 does not occur as robustly at
least in the early time points in response to laser-induced DNA damage. Since GFPUb can be incorporated into chains of endogenous Ub, it is also possible that GFPUb K11/K48/K63 mutant are more efficient than other mutants to be incorporated
into endogenous Ub chain. Nevertheless, the accumulation of GFP-K11 Ub to laser
tracks suggests that Lys11-linkage ubiquitination may occur at DNA damage sites.
This led us to characterize Lys11-linked ubiquitination in the DNA damage response
pathway.
3.3.2 Recruitment of ubiquitin Lys11-linkage-catalyzing E2 conjugating
enzymes to DNA damage site
Conjugation of Lys11-linkage ubiquitination at DNA damage sites indicates
that the corresponding E2 conjugating enzyme and E3 ligase may also accumulate
to DNA damage sites for assembly of the Lys11-linkage ubiquitin chains. Lys11linked polyubiquitination was first identified as a product of an E2-conjugating
enzyme Ube2S (also known as E2-EPF) (150). Ube2S and Ube2C (also known as
UbcH10) works in concert with the anaphase promoting complex/cyclosome
(APC/C) to assemble Lys11-linked ubiquitin chain, in which Ube2C initiates and
Ube2S elongates Lys11-linked polyubiquitin chain on APC/C
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Figure 21: Linkage specific ubiquitin conjugation in response to DNA
damage. A U2OS cells stably overexpressing either GFP-tagged-WT or Lys only
ubiquitin mutants were subject to laser micro irradiation with a UV laser. Live-cell
imaging was performed immediately after laser damage for 6 minutes with 30
seconds interval. Dotted line in the first image indicates laser micro irradiated
regions across the cell nuclei. Shown here are t=0 and t=3 minutes post-laser
micro irradiation. B. Lys11-linked ubiquitin conjugation at DNA damage sites.
Live-cell imaging of GFP-WT or -Lys63, Lys11 or Lys0 ubiquitin mutants at
indicated time-points post-laser micro irradiation. U2OS cells expressing GFP was
used as negative control.
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Figure 22 : Lysine11 ubiquitin conjugation enzymes localize to DNA damage
sites. A. Ube2S and Ube2C are associated with chromatin. Cell fraction analysis
was carried out with U2OS cells treated or not treated with 10 Gy IR followed by
30 min incubation at 37°C. B. Ube2S and Ube2C accumulate to DNA damage
sites. Images of U2OS cells stably expressing GFP-Ube2S or GFP-Ube2C were
laser microirradiated and live cell imaging was performed at indicated time points.
Western blot analysis of GFP-Ube2S or Ube2C expression levels was shown with
tubulin expression as a loading control. C. Ube2S co-localizes with γH2AX at DNA
damage sites. U2OS cells 5-10 min after laser-micro-irradiation were treated with
pre-extraction buffer and immunostained with antibodies to Ube2S and γH2AX. D.
Cdc20 and Cdh1 localization to DNA damage sites. U2OS cells stably expressing
GFP-Cdc20 or Cdh1 were subjected for laser micro-irradiation followed by live cell
imaging. Images at indicated times are shown.
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substrates (151-154, 163). APC/C is a large multisubunit RING-finger E3 ligase
complex including a catalytic core along with two additional co-activators Cdc20 and
Cdh1 that recruit substrates to the APC/C ligase complex during mitosis and G1
phases respectively. It plays a major function during cell cycle progression targeting
mitotic and G1 cell cycle specific regulators for proteasomal degradation (164, 165).
More recently studies done by Komander group identified an OTU family
deubiquitinase (DUB), Cezanne (also known as OTUD7B), which preferentially
cleaves Lys11-linked ubiquitin chain (157, 158). I first determined whether
Ube2S/Ube2C or the APC/C E3 ligase components accumulate to DNA damage
sites. Cell fractionation analysis showed that Ube2S and a portion of Ube2C are
associated with chromatin (Figure 22A). In addition, using live-cell imaging following
laser ablation in cells stably expressing GFP-tagged Ube2S and Ube2C, I observed
that GFP-Ube2S and to a lesser extent GFP-Ube2C were recruited to laser-induced
DNA damage tracks immediately after damage (Figure 22B). To further confirm
recruitment of Ube2S, I used a Ube2S-specific antibody to detect localization of
endogenous Ube2S to laser-induced DNA damage sites in U2OS cells and found
that endogenous Ube2S accumulates to damage sites marked with the DNA
damage marker γH2AX (Figure 22C). APC/C coactivators, CDC20 and CDH1 were
also appeared to be recruited to damage tracks after laser treatment (Figure 22D).
3.3.3 Ube2S/Ube2C dependent Lys11-linkage ubiquitin conjugation of
chromatin-bound proteins
Next, I examined whether Lys11-linkage ubiquitination occurs to chromatinbound proteins on damaged chromatin. To test this, I utilized biochemical approach
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by isolating chromatin fraction from cells transiently expressing HA-K11 Ub. Analysis
of chromatin-enriched fraction isolated from these cells showed that chromatin
ubiquitination by K11 Ub increased significantly upon IR-induced DNA damage and
was further enhanced by treatment with a proteasomal inhibitor, MG132 (Figure
23A). In addition, by comparing cells expressing HA-WT or mutant (K63, K48, and
K11) Ub, I found that ubiquitin modification by K11 Ub was at a level similar to that of
K63 or K48 Ub (Figure 23B). These findings confirm live-cell imaging data indicating
that Lys11-linked ubiquitination at damaged chromatin is as abundant as Lys63 and
Lys48-linked ubiquitination. A ubiquitin K0G76V mutant that cannot be conjugated to
substrates was included in the experiment as a negative control and showed no
conjugation of chromatin-bound proteins with this mutant ubiquitin (Figure 23B).
To determine whether Lys11-linkage chromatin ubiquitination is mediated by
Ube2S/Ube2C conjugating enzymes at DNA damage sites, I depleted endogenous
Ube2S and Ube2C using siRNAs from cells expressing HA-K11 Ub. Analysis of
chromatin fraction isolated from these cells showed significant impairment of K11linked ubiquitination of chromatin-bound proteins in Ube2S/Ube2C siRNAs (Figure
24A). Additionally, I found depletion of Ube2S alone impaired Lys11-linked
chromatin ubiquitination to a large extent (Figure 24B), suggesting that Ube2S
catalyzes K11-linkage ubiquitin chain formation on damaged chromatin. In order to
exclude any possibility of siRNA off-target effects, these results were further
confirmed with three different Ube2S siRNAs and as shown in Figure 24C, all three
Ube2S siRNAs impaired Lys11-linked chromatin ubiquitination. Moreover, to validate
Ube2S–mediated chromatin ubiquitination by K11 ubiquitin chain, I used siRNA-
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Figure 23 : IR-induced Lys11-linkage ubiquitination at damaged chromatin A
IR-induced Lys11-linkage chromatin ubiquitination. U2OS cells expressing HA-K11
Ub were either treated or not treated with 10 Gy IR followed by 1hr incubation at
37°C. MG132 (10 µM) was added 5 hr before IR.
B. Linkage-specific ubiquitination on chromatin in response to IR. U2OS cells
expressing HA-Ub WT or mutant were treated with IR similarly as in (A).
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Figure 24: IR-induced Lys11-linkage chromatin ubiquitination depends on
Ube2S/Ube2C enzyme A Ube2S/Ube2C are required for Lys11-linkage chromatin
ubiquitination. Cells expressing HA-K11 Ub were treated with control or
Ube2S/Ube2C siRNAs. 48 hours post transfection, cells were treated with MG132
and IR and chromatin fraction was isolated for HA antibody analysis. Whole cell
lysate (WCE) was used for western blot for assessing knockdown efficiency. B.
Ube2S depletion alone impairs Lys11-linked chromatin ubiquitination. U2OS cells
expressing HA-K11 Ub were transfected with siRNA targeting Ube2S. Chromatin
fraction was analyzed as in A. C. Three independent Ube2S siRNAs decreases
Lys11-linked chromatin ubiquitination. D. Ube2S catalyzes Lys11-linkage chromatin
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ubiquitination. Cells expressing HA-K11 Ub were transfected with control or
Ube2S siRNA along with GFP vector or GFP-tagged siRNA-resistant Ube2S, as
indicated. Chromatin fraction was isolated and analyzed with HA antibody. Whole
cell extract was used to detect knockdown efficiency.
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resistant Ube2S construct in the Ube2S-depleted cells and found that expression of
siRNA-resistant GFP-Ube2S can restore Lys11-linked chromatin ubiquitination in
Ube2S-depleted cells (Figure 24D). Together, these results indicate that chromatinbound proteins are modified with Lys11-linked ubiquitin modification in Ube2Sdependent manner.
3.3.4 APC/C E3 ligase-independent Lys11-linked chromatin ubiquitination
Since Ube2S/Ube2C functions with APC/C E3 ligase to catalyze Lys11-linked
ubiquitination on substrates that regulate cell cycle progression such as cyclin B, I
tested whether APC/C is required for Lys11-linkage modification on chromatin in
response to DNA damage. To test this, I depleted Apc2, a core component of the
APC/C E3 complex, in cells expressing HA-K11 Ub. While depletion of Apc2
abrogated APC/C’s E3 ligase function leading to stabilization of Cyclin B1 and an
increase of mitotic cells as marked by increased phospho-histone H3, this had
minimal effect on K11-linked chromatin ubiquitination in response to IR (Figure 25A).
Inhibition of APC/C by proTAME, an inhibitor to APC (166), also did not decrease
K11 Ub modification on damaged chromatin (Figure 25B). Moreover, knockdown of
the APC/C co-activator Cdh1 also did not result in a decrease of chromatin-level
K11-linked ubiquitin conjugation (Figure 25C). Together, these findings indicate that
Ube2S-catalyzed Lys11-linkage chromatin ubiquitination in response to DNA
damage is independent of APC/C E3 ubiquitin ligase.
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Figure 25 : APC/C-independent Lys11-linkage chromatin ubiquitination.
A. U2OS cells expressing HA-K11 Ub were transfected with control or Apc2
siRNAs. 48 hours post-transfection, cells were treated with MG132, irradiated and
chromatin fraction was isolated for western blot analysis with HA antibody. Total
cell lysates were blotted with indicated antibodies to confirm abrogation of APC/C’s
function in Apc2 knockdown cells. B. U2OS expressing HA-K11 Ub were treated
with APC/C inhibitor (proTAME 25 µM) for 18 hours before treatment with MG132
(or untreated) and IR. Chromatin fraction was isolated and analyzed with HA
antibody. H3 was used as loading control. C. Knockdown of Cdh1 does not
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decrease Lys11-linkage chromatin ubiquitination. U2OS cells stably expressing
control shRNA or shRNA targeting Cdh1 were transfected with HA-K11 Ub. 48 hr
post-transfection, chromatin fraction was isolated and analyzed by western blot
with HA antibody. Total cell lysates were analyzed to confirm knockdown
efficiency.
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3.3.5 Lys11-linked chromatin ubiquitination is dependent on ATM kinase and
upstream DDR factors
In response to IR-induced DNA damage, ATM-mediated phosphorylation of
histone H2AX (γH2AX) recruits MDC1 to DNA damage sites that initiates the
subsequent recruitment of RNF8 and RNF168 E3 ubiquitin ligases and Ubc13 E2
conjugating enzyme for Lys63-linkage ubiquitin chain assembly on histones H2A
and H2AX (37-39, 41, 43, 45, 143). Given the pivotal role of ATM kinase in triggering
DDR response immediately after DNA damage, I investigated whether the Lys11linkage ubiquitin modification on damaged chromatin is also regulated by ATM
signaling. Cells treated with siRNAs to ATM but not ATR greatly impaired K11-linked
ubiquitination on damaged chromatin to levels resembling those of Ube2S/Ube2C
depleted cells (Figure 26A), indicating that Lys11-linkage ubiquitin modification
occurs on damaged chromatin in an ATM-dependent manner. I further tested
whether depletion of other upstream DDR factors such as MDC1 as well H2A.X had
any effect in Lys11-linked chromatin ubiquitination. Interestingly, I found that
knockdown of MDC1 and H2AX also led to significant impairment of K11-linked
chromatin ubiquitination (Figure 26A and B).
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Figure 26 : Lys11-linkage chromatin ubiquitination is regulated by ATM,
MDC1 and RNF8 A. ATM and MDC1, but not ATR is required for Lys11-linkage
ubiquitination on chromatin in response to IR. U2OS cells treated with control or
Ube2S/Ube2C, ATM, ATR or MDC1 were transfected with HA-K11 Ub. 48 hours
post-transfection, chromatin fractions were extracted and analyzed with HA
antibody. Histone H3 was used as a loading control. Whole cell extracts were
analyzed with indicated antibodies to confirm knockdown efficiency B. H2AX is
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required for Lys11-linkage ubiquitination on damaged chromatin. Chromatin
fraction was isolated from cells transfected with control or H2A.X siRNAs and HA
K11 Ub and treated similarly as in A C. RNF8 regulates Lys11-linkage
ubiquitination on chromatin. Cells transfected with indicated siRNAs and HA K11
Ub were treated and analyzed similarly as in A. RNF8 knockdown efficiency is
measured by decrease of Abraxas IRIF. U2OS cells transfected with control or
RNF8 siRNAs treated with IR at 10 Gy followed by 2 hours incubation at 37°C
were analyzed by IF with Abraxas and γH2AX antibodies. More than 500 cells
were counted for quantification and cells containing more than 10 foci were
counted as positive. The data represents means± SD.
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3.3.6 RNF8 functions as an E3 ligase catalyzing Lys11 ubiquitin chain that is
deubiquitnated by the DUB Cezanne
Since my findings indicate that Lys11-linked chromatin ubiquitination occurs
in a manner independent of APC/C E3 ligase, I examined other enzymes known to
play role in catalyzing ubiquitination at damaged chromatin. To this end, I examined
whether Ubc13 and RNF8, enzymes known to catalyze Lys63-linked ubiquitination
at DNA damage sites, also regulate K11-linked ubiquitin conjugation on damaged
chromatin. Interestingly while depletion of Ubc13 appeared to have minimal effects
on Lys11-linked chromatin ubiquitination, I found that depletion of RNF8 completely
abrogated K11-linked chromatin ubiquitination to a level similar to that of the
Ube2S/Ube2C knockdown cells (Figure 26C), indicating that RNF8 may function as
an E3 ligase in catalyzing Lys11-linkage ubiquitination at DNA damage sites
independent of Ubc13. Of note, as described in sections 3.1.2 and 3.1.6, RNF8 has
been shown to catalyze both Lys63 and Lys48-linked ubiquitination by interacting
with distinct of E2 enzymes, Ubc13, and UbcH8, respectively. RNF8 is a RING
domain E3 ligase and one characteristic feature of many of the RING domain E3
ligases is to catalyze substrate-independent autoubiquitination (167). RNF8 has
been shown to undergo substrate-independent autoubiquitination synthesizing both
Lys63 and Lys48-linked chains by interacting with distinct E2 enzymes, Ubc13 and
UbcH8, respectively (57, 58). I hypothesized that if RNF8 indeed catalyzes Lys11linked ubiquitin chain in concert with Ube2S, it might also undergo Lys11-linked
autoubiquitination. To test this, I co-expressed Flag-RNF8 along with HA-K11,

98

Figure 27: RNF8 functions as an E3 ligase for Lys11-linked ubiquitination.
A. RNF8 autoubiquitination by Lys11-linkage modification. HEK293T cells were cotransfected with Flag-RNF8 and HA-K63, -K48 or -K11 Ub. 48 hours posttransfection, cells were irradiated with 10 Gy IR (or left untreated) followed by 30
min incubation at 37°C. Flag-immunoprecipitation was carried out under denaturing
condition. B. Lys11-linkage autoubiquitination of RNF8 in vitro. Purified HA-FlagRNF8 was eluted from Flag-beads after immunoprecipitation from lysates of
HEK293T cells expressing HA-Flag-RNF8. Equal amount of eluted Flag-RNF8 was
incubated in
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reaction mixtures containing purified ubiquitin, E1 and increasing amount of purified
Ube2S and Ube2C as indicated. C. Lys11-linkage autoubiquitination of RNF8 in vitro
using recombinant GST-RNF8. D. Ube2S alone can promote RNF8
autoubiquitination in vitro. In vitro autoubiquitination assay was performed in
presence of recombinant Ube2C (lane 4) or Ube2S (lane 5) or both (lane 6) and
GST-RNF8 similarly as in C. E. RNF8 interacts with Ube2S. HEK293T cells were cotransfected with Flag-RNF8 and GFP-Ube2S before treatment with IR.
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K63, K48 or K0 Ub in cells and examined linkage-specific RNF8 self-ubiquitination
under denaturing condition. This analysis revealed that in addition to previously
reported K63- and K48-linked autoubiquitination; RNF8 is also modified by Lys11linked polyubiquitin chain, suggesting that RNF8 may act as an E3 ligase for Lys11linked ubiquitination (Figure 27A). To validate RNF8’s role as an E3 ligase that in
concert with Ube2S/Ube2C catalyzes Lys11-linkage ubiquitination, I tested whether
Ube2S/Ube2C assist in autoubiquitination of RNF8 in vitro. Purified RNF8 eluted
from Flag-immunoprecipitates from cell lysates (Figure 27B) or recombinant GSTRNF8 was incubated in vitro with ubiquitin in the presence of purified E1 and
Ube2S/Ube2C E2 enzymes (Figure 27C). The findings obtained from this in vitro
ubiquitination assays showed that Ube2S/Ube2C facilitated self-ubiquitination of
RNF8 in vitro. Moreover, I tested whether Ube2S alone can facilitate RNF8
autoubiquitination. As shown in Figure 27D, in vitro RNF8 autoubiquitination assay in
presence of Ube2S or Ube2C or both confirmed that Ube2S alone can catalyze
RNF8 autoubiquitination under this condition. Furthermore, I reason that if Ube2S
and RNF8 coordinate with each other to catalyze Lys11-linked ubiquitination, they
might also interact with each other. Since endogenous E2-E3 interaction is difficult to
detect due to transient nature of this interaction (106, 168), I co-expressed FlagRNF8 with GFP-Ube2S or GFP-Ube2C in HEK293T cells. Co-immunoprecipitation
analysis showed that Flag-tagged RNF8 interacted with GFP-tagged Ube2S (Figure
27E) but not Ube2C (data not shown) in the presence of IR; consistent with the idea
that RNF8 E3 ligase works with Ube2S to assemble Lys11-linked chains.

101

Figure 28 : RNF8-dependent Lys11-linkage ubiquitination is antagonized by
Cezanne. U2OS cells were transfected with indicated siRNAs individually or in
combination, followed by transient transfection of HA-K11 Ub. 48 hours posttransfection, cells were treated with MG132, irradiated and chromatin fraction was
isolated for western blot analysis with HA antibody. Knockdown efficiency of
individual gene was confirmed by western blot analysis of whole cell lysate with
indicated antibodies (right panel).
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Finally, to further confirm that RNF8 promotes Lys11-linkage ubiquitin
modification, I examined whether Cezanne, a DUB that specifically cleaves the
Lys11-linkage ubiquitin conjugates (157), antagonizes the activity of RNF8 in Lys11linkage ubiquitin modification of chromatin-bound proteins. Indeed, while knockdown
of RNF8 decreased the Lys11-linkage ubiquitin modification, depletion of Cezanne in
RNF8-deficient cells significantly reversed the decrease of Lys11-linkage
ubiquitination, indicating that RNF8 and Cezanne function in the same pathway to
modify Lys11-linkage ubiquitin conjugation on damaged chromatin (Figure 28).
Taken together, these findings conclusively suggest that RNF8 acts as an E3 ligase
that in association Ube2S E2 conjugating enzyme catalyzes Lys11-linked chromatin
ubiquitination at the damaged chromatin.
3.3.7 Histone H2A/H2A.X are modified with Lys11-linked ubiquitin conjugates
in DNA damage-dependent manner
My findings indicate that chromatin-bound proteins undergo Lys11-linked
ubiquitination by Ube2S-RNF8 enzymes in DNA damage-dependent manner.
Because histone proteins are the fundamental unit of chromatin structure and are
subjected to extensive post-translational modifications including ubiquitination, I
examined whether histones are modified by Lys11-linkage ubiquitin conjugates. To
test this, I undertook multiple biochemical approaches. First, I used acid extraction to
isolate all histone proteins from cells expressing HA-tagged WT or Lys only mutant
Ub. Acid extraction of highly basic histone proteins is a standard procedure to isolate
histone proteins from chromatin. Robust ubiquitination of acid-extracted proteins,
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Figure 29 : Histone proteins are modified with Lys11-linked ubiquitination.
Linkage-specific ubiquitination of acid-extracted histone faction. U2OS cells
expressing HA-WT or mutant Ub were treated with MG132, irradiated followed by
acid extraction to isolate highly basic histone proteins. Histone H3 was used as
loading control. Bottom panel: Ponceau staining of acid-extracted histones is
shown. B. DNA damage-induced Lys11-linkage ubiquitination of histone
H2A/H2AX. HEK293T cells co-transfected with Flag-H2A or -H2AX and HA-K11 Ub
were irradiated at 12 Gy and incubated at 37°C for 1 hour. Flagimmunoprecipitation was carried out under denaturing condition as described in
material and methods. Bottom panel: Flag immunoblot showing immunoprecipitated
Flag-tagged histone proteins.

104

presumably mainly histones, by HA-WT Ub could be seen with western blot.
Interestingly, the level of ubiquitin modification by K11 Ub was similar to that of K63
and K48 Ub, suggesting that Lys11-linkage formation occurs as extensively as the
Lys63- or Lys48-linkage formation on histones (Figure 29A). These findings again
corroborate my live-cell imaging data of Lys11-linked ubiquitination at damaged
chromatin (Figure 21). Second, to examine which histone protein(s) is modified with
Lys11-linked ubiquitination, I co-expressed Flag-tagged individual histone proteins,
including H2A, H2AX, H2B, H3, and H4 along with HA-K11 Ub in HEK293T cells and
treated the cells with IR to induce DNA damage. Analysis of Flagimmunoprecipitation done under denaturing condition revealed that among all
histone proteins, histone H2A and H2AX were modified with K11 Ub in a DNA
damage-dependent manner. Analysis of Lys11-linkage ubiquitin modification on
other histone proteins showed that H2B was also modified by K11-linked ubiquitin
but the modification was independent of IR and that H3 and H4, on the other hand,
did not show modification by K11-linked ubiquitin (Figure 29B).
I then set out to confirm whether endogenous histone H2A/H2A.X are modified
by Lys11-linkage ubiquitination upon DNA damage. Utilizing a previously published
system expressing a tandem hexahistidine-biotin tag (HBT-tag) fused to ubiquitin for
purification of ubiquitinated proteins under fully denaturing conditions (113), I
generated HeLa cells stably expressing HBT-K11 Ub. Analysis of streptavidin beads
pull-down proteins under complete denaturing condition (8M Urea) and by western
blot with antibodies to ubH2A, H2A or γH2A.X revealed that
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Figure 30 : Endogenous histone H2A/H2A.X are modified with Lys11-linked
ubiquitination. A. Left panel: Schematic for detection of endogenous histone H2A
modification with Lys11-linked ubiquitin conjugates under denaturing condition.
Right panel: Streptavidin pulldown proteins were analyzed with western blot using
antibodies to ubiquitinated H2A (ubH2A). B and C. Hela cells expressing HisBiotin-K11 Ub were subjected to treatment as described in Figure A and were
analyzed with antibodies again H2A (B) and γH2A.X (C).
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Figure 31: RNF8 and Ube2S/Ube2C catalyze histone H2A ubiquitination in
vitro. A. Recombinant histone H2A was incubated with a reaction mixture
containing purified ubiquitin, E1, increasing amount of Ube2S/Ube2C (lanes 3-4
and 5-6), in the presence (lane 5 & 6) or absence (lanes 1-4) of purified HA-FlagRNF8. Reaction mixtures were analyzed by western blot with FK2 antibody. B. H2A
ubiquitination in vitro. H2A/H2B dimer was used in the reaction as described in (A).
The western blot was carried out with ubH2A antibody. C. In vitro ubiquitination by
RNF8 and Ube2C/Ube2S using nucleosome as substrates.
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endogenous histone H2A/H2AX could be modified by K11-Ub conjugates and this
modification was somewhat enhanced in response to IR (Figure 30). Finally, I tested
whether histone H2A is a substrate directly modified by RNF8 and Ube2S/Ube2C
using in vitro ubiquitination assay. I incubated purified H2A with ubiquitin, E1,
Ube2S/Ube2C and HA-Flag-RNF8 and examined the conjugation of ubiquitin on
H2A by the FK2 antibody or ubH2A antibody. It showed that polyubiquitination of
H2A was triggered when purified RNF8 was present, suggesting that H2A is a direct
substrate of RNF8 (Figure 31A). Ubiquitination of H2A recognized by ubH2A
antibody was also shown when histone H2A/H2B dimer was used in the reaction
(Figure 31B). Similar findings were also observed when I used nucleosome as
substrate for in vitro ubiquitination reaction (Figure 31C). Together, these findings
confirm that RNF8 functions with Ube2S to assemble Lys11-linkage ubiquitin chains
on substrates including H2A.
3.3.8 RNF8 and Ube2S catalyze Lys11-linked H2A ubiquitination in DNA
damage-dependent manner
Next, I tested whether Ube2S and RNF8 are required for Lys11-linkage
ubiquitin modification of H2A. I depleted Ube2S or RNF8 in HEK293T cells
expressing Flag-tagged H2A and HA-K11 Ub. My findings indicate that depletion of
Ube2S or RNF8 by siRNAs led to a marked decrease of K11-linked
polyubiquitination of H2A, indicating that Ube2S and RNF8 are required for
catalyzing Lys11-linkage ubiquitination of H2A in response to IR (Figure 32A). Since
Lys11-linked ubiquitination was identified as a proteolytic signal for mitotic proteins, I
tested whether modification of histones H2A and H2A.X triggers degradation of
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Figure 32: Ube2S and RNF8-dependent Lys11-linkage ubiquitination of
histone H2A/H2AX in response to DNA damage. A. HEK293T cells depleted of
Ube2S or RNF8 were co-transfected with Flag-H2A and HA-K11 Ub. 48 hours posttransfection, cells were treated with MG132 (or left untreated), irradiated at 12 Gy
(or untreated) followed by lysis and Flag-immunoprecipitation under denaturing
condition and western blot analysis with indicated antibodies. Whole cell extracts
were immunoblotted with indicated antibodies to confirm knockdown efficiency.
Right panel: Confirmation of RNF8 knockdown efficiency. U2OS cells transfected
with control or RNF8 siRNAs were analyzed by IF for Abraxas IRIF formation. Cells
containing 10 or more foci were counted as positive and the data represents
means± SD. B. Endogenous H2A/H2AX protein levels are not affected in Ube2Sdeficient cells. Chromatin fraction from U2OS cells transfected with control or
Ube2S siRNAs was analyzed by western blot with indicated histone antibodies.
PCNA protein level was used as a loading control. Total cell lysates were analyzed
by western blot for knockdown efficiency.
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these proteins. Analysis of endogenous histones H2A and H2A.X in presence or
absence of DNA damage and/or proteasomal inhibitor MG132 revealed no alteration
in chromatin-bound histone protein level in control and Ube2S depleted cells
indicating Lys11-linked ubiquitination of histone is not a proteolytic signal (Figure
32B).
3.3.9 Lys11-linkage ubiquitination does not interfere with Lys63-linked
ubiquitination-dependent recruitment of 53BP1 and BRCA1
We reason that, if RNF8 functions with Ube2S/Ube2C, but not Ubc13, in
regulating Lys11-linkage ubiquitin modification, knocking down Ube2S/Ube2C
should not interfere with the Ubc13-dependent Lys63-linkage ubiquitin conjugation at
damaged chromatin that recruits 53BP1 and BRCA1 to DNA damage sites. To test
this, I utilized multiple approaches. First, I examined whether depletion of
endogenous Ube2S impairs chromatin-bound proteins modification by Lys63-linked
ubiquitin. Isolating chromatin fraction from Ube2S depleted cells showed that Ube2S
depletion had minimal effect on Lys63-linked chromatin ubiquitination (Figure 33). In
addition, I tested IR-induced foci formation (IRIF) of 53BP1 and Abraxas/BRCA1-A
complex (41, 47) components in Ube2S/Ube2C depleted cells. Consistent with a role
of Ube2S in forming DNA damage-induced ubiquitin conjugates at DNA damage
sites, IF staining with the FK2 antibody that detects ubiquitin chains showed a
significant decrease of ubiquitin foci formation in Ube2S/Ube2C (Figure 34).
However, knockdown of Ube2S/Ube2C did not appear to have a major effect on
affecting IRIF of 53BP1, BRCA1, Abraxas, or Rap80 (Figure 35), indicating that
Lys11-linkage ubiquitin modification does not directly interfere with the Lys63-linkage
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F Figure 33: Ube2S knockdown effect on chromatin ubiquitination modified by
HA-WT, K63 or K0 Ub. U2OS cells treated with control or Ibe2S siRNAs were
transfected with HA-K11 Ub. 48 hours post-transfection, chromatin fractions were
extracted and analyzed with HA antibody. Histone H3 was used as a loading
control. Whole cell extracts were analyzed with indicated antibodies to confirm
knockdown efficiency.
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F Figure 34 : Lys11-linkage ubiquitination is dispensable for recruitment of DNA
damage repair proteins 53BP1 and BRCA1-A complex proteins.
U2OS cells were transfected with control siRNA or siRNAs targeting
Ube2S/Ube2C. 48 hr post-transfection, cells were irradiated with 10 Gy IR,
incubated for 2 hr at 37°C followed by immunostaining with antibodies to
conjugated ubiquitin (FK2 antibody) (A), 53BP1 (B), BRCA1 (C), Abraxas (D), or
Rap80 (E). Percentage of foci-positive cells (cells containing more than 10 foci) was
quantified and indicated as means± SD with p-value indicated. The experiments
were repeated three times with more than 500 cells counted each time, and
representative images are shown.
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Figure 35: Lys11-linkage ubiquitination is dispensable for recruitment of DNA
damage repair proteins 53BP1 and BRCA1 in Ube2S depleted cells. U2OS
cells were transfected with control or siRNAs targeting Ube2S (siRNA#1). 48 hr
post-transfection, cells were irradiated with 10 Gy IR followed by 2 hr incubation at
37°C followed by immunostaining with antibodies to conjugated ubiquitin (FK2
antibody) (A), 53BP1 (B), BRCA1 (C), Abraxas (D). Percentage of foci-positive
cells (cells containing more than 10 foci) was quantified and indicated as means±
SD with p-value indicated. E. Whole cell extracts were analyzed for Ube2S
knockdown efficiency. Tubulin was used as a control.
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ubiquitin conjugation-mediated recruitment of 53BP1 and Abraxas/BRCA1-A
complex. Since Ube2C has been shown to catalyze Lys63, Lys48 and Lys11-linked
ubiquitination, while Ube2S is Lys11-Ub specific E2 conjugating enzyme, I further
confirmed the IRIF of 53BP1 and of BRCA1-A complex components in Ube2S only
depleted cells. And as shown in Figure 35, depletion of Ube2S alone appeared to
have a similar phenotype as dual depletion of Ube2S and Ube2C. Taken together,
these data, suggest that the role of RNF8 in regulating Lys11-linkage modification is
independent of its role in catalyzing Lys63-linkage ubiquitin conjugation at DNA
damage sites.
3.3.10 Lys11-linked ubiquitination at damaged chromatin is required for
regulation of DNA damage-induced transcription silencing
Histone ubiquitination is often associated with transcription regulation (169172). In addition, a recent study by Greenberg and colleague showed that RNF8
plays an essential role in inducing transcription inhibition at DSBs (67). To find out
the functional significance of Ube2S-RNF8-mediated Lys11-linked chromatin
ubiquitination, I tested whether Lys11-linkage ubiquitination is involved in regulating
transcriptional silencing at the sites of DNA damage. To examine this, I utilized the
Click chemistry-based imaging to measure the nascent transcript production at the
sites of DNA damage induced by laser micro irradiation as described by Gong et al,
2015 and depicted in Figure 36A. In this assay system, I monitored nascent RNA
transcript production at laser micro irradiated DNA damage sites using 5-ethynyl
uridine (EU), a nucleoside analog of uracil, which is incorporated into nascent RNA
during active transcription (173). Using this system I first confirmed whether RNF8
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Figure 36: Lys11-linkage ubiquitination regulates DNA damage-induced
transcription silencing. A. A scheme for examining DNA damage-induced
transcription inhibition as described in materials and method section. B. Detection
of 5-EU labeling and gH2AX staining 1 hr post laser-microirradiation in control and
RNF8 siRNA-transfected U2OS cells. C. Ube2S/Ube2C-deficient cells are defective
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in DNA damage-induced transcription inhibition. D. Quantification of 5-EU
intensity normalized by γH2AX intensity in the laser-damaged region. E. Ube2Sdeficient cells are defective in DNA damage-induced transcription inhibition. EU
labeling and γH2AX staining was performed similarly as in B and C. F.
Quantification of E. 5-EU intensity was measured along the laser tracks and
normalized by γH2AX intensity along the same laser-damaged region.
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depletion had any effects in transcription silencing as reported by Shanbhag et al,
2012. Consistent with previous findings, I found compared to control siRNA
transfected cells, transcription silencing was significantly impaired in RNF8 depleted
cells as indicated by enrichment of EU intensity along the γH2A.X marked damaged
region Figure 36B. These findings corroborate previous findings of RNF8’s role in
transcription silencing at the sites of DNA damage. Interestingly compared to that in
control cells in which nascent transcript production was inhibited at laser micro
irradiation-induced DNA damage sites, in Ube2S/Ube2C depleted cells,
transcriptional silencing after DNA damage is significantly reduced (Figure 36C).
Quantification of EU intensity normalized over γH2AX intensity showed significant
enrichment of EU labeling along the damage region of the chromatin in
Ube2S/Ube2C siRNA transfected cells (Figure 36D). Moreover, to test whether
depletion of Ube2S alone can impair transcription silencing at damaged chromatin, I
measured nascent transcript production in Ube2S depleted cells. Quantification of
EU intensity normalized to γH2AX intensity showed that Ube2S deficiency alone can
affect transcription silencing at DNA damage sites (Figure 36E and F).
To further validate these findings, I tested RNAPII phosphorylation status.
RNAPII transcribing activity correlates with the phosphorylation status of RNA
polymerase II carboxy-terminal domain (CTD) in hepta-repeats YSPTSPS. Active
transcription is associated with hyperphosphorylation of the C-terminal domain
(CTD) of RNA polymerase II (RNAPII), whereas it remains hypophosphorylated in
non-elongating RNAPII complexes (174-177). To test the effect of Ube2S/Ube2C
depletion in RNAPII phosphorylation status, I monitored the phosphorylation state of
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Figure 37: Increased RNAPII phosphorylation and IR sensitivity in
Ube2S/Ube2C depleted cells in response to IR. A. Increased RNAPol II
hyperphosphorylation in Ube2S/Ube2C-deficient cells. U2OS cells stably
expressing indicated shRNAs were irradiated with 10 Gy IR, harvested at indicated
time-points and nuclear fractions were isolated for western blot analysis. IIo and IIa
designate hyperphosphorylated and hypophosphorylated forms of the large subunit
Rpb1 of RNA Pol II respectively. B. Quantification of Rpb1 hyperphosphorylation
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in Ube2S/Ube2C-deficient cells. Hyperphosphorylated Rpb1 and
hypophosphorylated Rpb1 (IIa) band intensities were measured by ImageJ and
normalized to untreated samples. C. Chromatin fraction analysis of increased
RNAPII hyperphosphorylation in control and Ube2S/Ube2C deficient cells. D.
Quantification of C. E. Increased cellular sensitivity of Ube2/Ube2C-deficient cells
to IR. Percentage of survival in the clonogenic survival assay is quantified and
presented as means ± SD.
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RNAPII by using an antibody that recognizes both hyperphosphorylated and
Hypophosphorylated (IIa) forms of RNAPII. As shown in Figure 37A analysis of
nuclear fraction showed that hyperphosphorylation of RNAPII decreased significantly
in control cells after 1 hour post-IR-induced DNA damage followed by recovery at
later time points, indicating silencing of active transcription at damaged chromatin
after DNA damage. Interestingly, compared to control cells, hyperphosphorylation
status of RNAPII in Ube2S/Ube2C-deficient cells did not decrease particularly at 1
hour after IR treatment, indicating that active transcription is not efficiently inhibited
in Ube2S/Ube2C-deficient cells in response to IR (Figure 37A and B). This was also
confirmed when chromatin fraction was analyzed for RNAPII phosphorylation state
(Figure 37C and D). Collectively, these data indicate that Ube2S/Ube2C-mediated
Lys11-linkage ubiquitination plays a crucial role in promoting transcriptional silencing
on the damaged chromatin. In consistent with a role of Lys11-linkage ubiquitination
in the DDR, I also found that depletion of Ube2S/Ube2C led to a marked increase in
cellular sensitivity to IR (Figure 37E). Thus Lys11-linkage ubiquitination is likely to
play a critical role in the cellular response to DNA damage.
Collectively, in this study, we report ubiquitin Lys11-linkage conjugation as a
new platform of ubiquitin landscape on damaged chromatin in the cellular response
to DNA damage. I show that Lys11-linkage ubiquitination occurs on damaged
chromatin and is regulated by ATM-dependent signaling. I identify the corresponding
ubiquitin modifying enzymes responsible for the Lys11-linkage ubiquitin events at
DNA damage sites including Ube2S/Ube2C E2 conjugating enzymes, RNF8 E3
ligase and Cezanne deubiquitinating enzyme. Moreover, I find that histone
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H2A/H2AX is a target of this modification on damaged chromatin. Importantly, I
show that Lys11-linkage ubiquitin conjugation plays a critical role in the regulation of
DNA damage-induced transcription silencing, distinct from the role of Lys63-linkage
ubiquitin in the recruitment of 53BP1 and BRCA1 DNA damage repair proteins.
3.4 Discussion
Chromatin modification at DNA damages sites constitutes an immediate
component of the cellular response to DNA damage for signaling and repair.
Proteomic analysis of global ubiquitination profiling reveals assembly of all seven
lysine residue-linked ubiquitination in a varying degree of abundance in both yeast
and mammalian cells (113, 114, 159). However, much is still missing for
understanding the role of linkage-specific ubiquitin chains in the regulation of DNA
damage response and repair. My findings in this study, for the first time, reveals a
connection between Lys11-linkage ubiquitination, one of the most abundant ubiquitin
linkages (114), to DNA damage response. It provides evidence that Lys11-linkage
ubiquitin chains occur extensively at DNA damage sites in an ATM-dependent
manner with kinetics and degree of conjugation similar to that of Lys63- and Lys48linkages, putting Lys11-linkage ubiquitin modification as a yet another important
aspect of the ubiquitin landscape at sites of DNA damage (Figure 38).
In this study, I have identified the ubiquitin enzymatic machinery that
assembles and disassembles Lys11-linkage ubiquitin modification at the DNA
damage sites. I found that E2 conjugating enzyme Ube2S and E3 ligase RNF8
catalyze Lys11-linked Ub modification at damaged chromatin. Ube2S was identified
as a bona fide E2 enzyme that functions in concert with APC/C E3 ligase complex to
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elongate the Lys11-linked ubiquitin chain initiated by Ube2C, another cognate E2
conjugating enzyme that can also assemble Lys63 and Lys48-linked ubiquitin chains
substrates (129, 151-154, 163, 178). Although APC/C has been extensively shown
to partner with Ube2S and Ube2C in catalyzing Lys11-linked ubiquitination during
mitosis and G1 phases of the cell cycle, in our analysis I found Ube2S does not
partner with APC/C to assemble Lys11-linked polyubiquitin conjugates. While
depletion of Ube2S alone abrogates Lys11-linked chromatin ubiquitination, it is
largely unaffected by APC/C inactivation. Instead, my findings identify RNF8 as a
new partner E3 ligase that works with Ube2S for the DNA damage-induced Lys11linkage ubiquitin conjugation on chromatin-bound proteins including histone H2A
both in vitro and in vivo. RNF8-deficient cells abolish both Lys11-linked chromatin
and histone H2A ubiquitination to the same degree as Ube2S depleted cells
indicating that these two enzymes work in concert to catalyze Lys11-linked
polyubiquitin conjugates at damaged chromatin. In addition, I found that Ube2S and
RNF8 interact with each other and RNF8 is self-ubiquitinated in Ube2S-dependent
manner. Since Ube2S has specificity to assemble only Lys11 ubiquitin chain, these
findings confirm that RNF8 is autoubiquitinated by Lys11 ubiquitin. Interestingly, it
has been shown that RNF8 is capable of interacting with several different E2
conjugating enzymes in response to DNA damage, including Ubc13 for Lys63linkage (37-39, 41), UbcH5C for Lys6-linkage (140) and UbcH8 for Lys48-linkage
(57, 58) ubiquitination. This is consistent with the notion that chain specificity is an
intrinsic property of E2 enzymes and E3 ligases interact with different E2s
generating linkage-specific ubiquitin chains (106, 118). Therefore, RNF8 appears to

122

function as a ‘master E3 ligase’ at the DNA damage sites generating different Lys
residue-linked ubiquitination by interacting with different E2 conjugating enzymes.
One question that arises from these observations is “how these different types of
ubiquitin chains are coordinated at the DNA damage sites?” Although we are still
away from understanding the full spectrum of the complexity of ubiquitin signaling at
the damage sites, it is tempting to speculate that many of the E3 ligases, previously
known to catalyze single type of ubiquitin chain, may interact with other E2 enzymes
at the damage sites to assemble different linkage-specific ubiquitination. Along with
RNF8’s role to generate multiple different chain types, as discussed in section 3.1.4,
recent findings from Penengo and colleague showed that RNF168 is also involved in
catalyzing Lys27-linked ubiquitination at DNA damage sites (56). Together, E3 ligase
interaction with the distinct E2 enzyme is likely to be a central mechanism for
coordination of linkage-specific ubiquitination at sites of DNA damage.
Ubiquitin conjugation is a dynamic enzymatic activity that is regulated by the
precise balance between enzymatic activities of the ligase and DUB that cleaves the
polyubiquitin chain and thereby regulates downstream signaling (89). Ubc13mediated Lys63-linked polyubiquitin chain at damage sites is disassembled by
BRCC36, a DUB present in the BRCA1-A complex (41, 54, 88, 91). In this study, we
identify that Cezanne, a DUB that has been shown to preferentially deubiquitinate
Lys11-linked ubiquitin chain (157), regulates DNA damage-induced Lys11-linkage
ubiquitination, antagonizing the RNF8- and Ube2S-dependent assembly of Lys11linkage chains. Thus, our data illustrates Lys11-linkage modification as an
independent posttranslational modification utilizing distinct E2 conjugating enzyme,
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E3 ligase and DUB for assembly and disassembly of ubiquitin chains at DNA
damage sites.
Chromatin ubiquitination plays a crucial role in the DNA damage response (4,
162). Functional significance of linkage-specific ubiquitination at DSBs has just
begun to emerge. The best-illustrated example is Lys63-linkage ubiquitination in
response to DNA damage and activation of ATM. The RNF8/RNF168- and Ubc13catalyzed Lys63-linkage ubiquitin chains assembled on damaged chromatin provide
docking sites for the recruitment of 53BP1 and BRCA1-A complex (4, 162). The
study done by Penengo group indicates that Lys27-linked ubiquitination of
H2A/H2AX generated by RNF168 adds an additional layer of regulation by linkagespecific ubiquitination facilitating the accumulation of 53BP1 and BRCA1 forming
IRIF (56). Lys48-linkage formation, on the other hand, modifies Ku80 and regulates
its abundance at DNA damage sites for modulation of non-homologous end joining
repair (57). Thus, the type of ubiquitin linkage is likely to determine the functional
outcome of the modification. In this report, I found that although disruption of Lys11linkage formation significantly decreased the ubiquitin conjugates detected by the
FK2 antibody at DNA damage-induced foci, it has minimal effect on the recruitment
of 53BP1 or BRCA1, distinct from the role of Lys63- or Lys27-linkage ubiquitin
chains. Rather, Ube2S- and RNF8- mediated Lys11-linkage formation plays an
important role in regulating DNA damage- induced transcriptional silencing.
Transcription in regions near DNA damage site is temporarily inhibited in an ATMand DNAPK-dependent manner for proper DNA repair and transcription activities to
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maintain genome stability (67, 179). However, how the transcriptional silencing is
achieved at DSB sites still remains elusive. Our study uncovers a novel role of
Lys11-linked chromatin ubiquitination in promoting transcriptional repression at
DSBs. It is possible that Lys11-linked ubiquitin modification of H2A/H2AX directly
contributes to the recruitment of transcriptional repressor complexes or adopting a
chromatin environment that enhances repression of transcription locally at sites of
damage. In fact, histone ubiquitination has been implicated extensively in
transcriptional regulation (180). Ubiquitination of histone H2A (uH2A) accumulates at
DNA damage sites and is correlated with transcriptional repression (169-172). It is
also indicated that ATM- and RNF8-dependent ubiquitination of H2A promotes DNA
damage-induced transcription repression (67). Our study expands this knowledge
and suggests that RNF8 may regulate the DNA damage-induced transcriptional
silencing through catalyzing Lys11-linkage ubiquitin modification of H2A/H2AX.
Alternatively, additional substrates of Lys11-linkage modification may be involved in
promoting transcriptional silencing through additional mechanisms such as
influencing the phosphorylation of RNA polymerase II.
Lys11-linked chain type has been considered as a degradative chain type,
along with Lys48-linked ubiquitin polymers, promoting proteasome-dependent
degradation of substrates. The Lys11-linkage ubiquitin chain assembly on APC/C
substrates Cyclin B1 and Securin during mitosis and G1 phases leads to their
degradation and regulating cell cycle progression (151-154). Although the study of
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Figure 38: A proposed model for the Lys11-linkage ubiquitination at sites of
DNA damage. DNA damage induces an ATM-MDC1-dependent Lys11-linked
ubiquitination at damaged chromatin mediated by Ube2S conjugating enzyme and
RNF8 ligase and is deubiquitinated by the DUB Cezanne. Lys11-linked chromatin
ubiquitination modifies histone H2A and H2A.X at damaged chromatin along with
other unidentified chromatin-bound proteins and while Lys11-linked chromatin
ubiquitination does not regulate DDR factor recruitment to DSB sites, it plays an
essential role in regulating transcription silencing.
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aiming to examine the role of Lys11-linkage ubiquitin modification in various cellular
processes is still limited, Lys11-linked ubiquitin chain conjugation also has been
implicated in non-proteolytic pathways such as NF-κB activation (181-183). In our
study, we didn’t observe any changes in the steady-state level of chromatin-bound
H2A/H2AX in cells depleted with Ube2S in presence or absence of DNA damage,
indicating that Lys11-linked ubiquitination of histone H2A/H2AX is less likely to
represent a proteolytic signal for protein degradation. However, we could not exclude
the possibility that other yet unknown substrates of Lys11-linkage modification on
damaged chromatin undergo proteasome-dependent degradation due to this
modification. Recent crystallographic and NMR analysis showed that Lys11-linked
di-ubiquitin adopts a compact structure distinct from the Lys48- and Lys63-linked
ubiquitin chains (157, 184, 185), suggesting that Lys11-linked chains are capable of
representing an independent signaling entity within cells.
In summary, this study demonstrates that Lys11-linkage ubiquitin modification
is an important aspect of the complex ubiquitin landscape that exists in the vicinity of
DNA damage regulating DNA damage-induced transcriptional silencing. My findings
emphasize the complexity of ubiquitin signaling at the sites of damage involving
different E2-E3 pair to assemble different ubiquitin linkages. It highlights the
importance of linkage-specific ubiquitination in the DDR and supports the notion that
polyubiquitin chains with different linkages should be regarded as independent
posttranslational modification.
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3.5 Future directions:
This study provides evidence for the first time that damaged chromatin is
modified with Lys11-linked ubiquitin chain in an ATM-dependent manner by Ube2S
and RNF8 enzymes and Lys11-linked chromatin ubiquitination is essential for
inducing transcriptional silencing in the vicinity of the DNA damage. Although these
findings expand our understanding of the linkage-specific ubiquitination at the DNA
damage sites, this study also raises several important questions that require further
investigation. First, I found that Ube2S/Ube2C depleted cells become sensitive to IRinduced DNA damage indicating these enzymes may involve in cellular resistance to
IR and likely to play a role in DNA repair. However, the exact role of this enzymes
and Lys11-linked ubiquitination in DNA repair still remains to be determined.
Transcriptionally active regions have been shown to favor HR repair (186). Given I
found that active transcription is not efficiently inhibited at the damage sites in
Ube2S/Ube2C depleted cells, it will be interesting to examine whether depletion of
Ube2S/Ube2C have any effects on HR repair. Second, my findings indicate that
histone H2A/H2A.X are modified with Lys11-linked ubiquitin chain in DNA damagedependent manner. However, the identity of the lysine residue(s) on histone H2A
that is modified with Lys11 ubiquitin chain still requires further examination. H2A is
known to be modified with Lys63-linked ubiquitin chain at Lys13 and Lys15 residue
on H2A (143). A proteomic analysis of in vivo ubiquitination sites identified novel
sites for ubiquitination on different histone proteins (142). Therefore, site-directed
mutagenesis analysis should be performed to identify and characterize the H2A
lysine residue(s) that is modified with Lys11 ubiquitin chain. Third, it is possible that
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other non-histone proteins are also modified with Lys11-linked ubiquitin chain at the
damage sites. Identification and characterization of these substrates will further our
understanding of the role of Lys11-linked chromatin ubiquitination at the DNA
damage sites. Fourth, does Lys11-linked ubiquitin chain trigger proteolytic signal at
the damage sites? The chromatin fraction analysis showed that chromatin-bound
protein modification with Lys11 ubiquitin chain is enhanced dramatically upon
treating the cells with MG132. This raises the possibility that a fraction of the Lys11
ubiquitin-modified proteins is likely to be targeted by the proteasome. Although I
could not detect any alteration in histone protein levels, it is possible that other nonhistone proteins may undergo proteasomal degradation by Lys11-linked
ubiquitination in DNA damage-dependent manner. Fifth, although my study uncovers
a novel role of Lys11-linked chromatin ubiquitination in inducing transcriptional
silencing at the DNA damage sites, the mechanism of this silencing event requires
further investigation. There are several possibilities that can be tested to figure out
the mechanism of transcription silencing at damaged chromatin. It is possible that
histone H2A ubiquitination in the Lys11-linked manner directly recruits transcriptional
repressor complex. Another possibility is, components of the RNAPII holoenzyme
may be modified and degraded by Lys11 ubiquitin chain and thereby inducing
transcription stalling until the damage is repaired. These possibilities should be
tested in future studies. And lastly, given recognition of different ubiquitin chain by
specific ubiquitin binding domain (UBD) containing proteins contributes to a diverse
set of functional outcome, it will be interesting to examine specific UBDs that can
bind to Lys11 ubiquitin chain. Identification of UBDs that recognize Lys11 ubiquitin
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chain will, therefore, likely to reveal novel function this modification at the DNA
damage sites as well as other signaling events in the cell.
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CHAPTER 4
DISCUSSION AND FINAL WORDS
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4.1 Discussion
Since the discovery of DNA structure, a remarkable amount of effort has been
dedicated to understanding how cells preserve its genetic material to maintain
genetic integrity. It is the largest molecule that is subject for numerous lesions. It is
estimated that cells experience around 104 to 106 DNA lesions per cell per day.
Nevertheless, the cells must keep the DNA intact by deploying a repertoire of repair
mechanisms in proliferating cells as well as in germ cells to ensure faithful
transmission across generations (3, 4). Given injury to DNA interferes with DNA
replication and transcription, resulting in genome instability, the DNA damage
response signaling has evolved as the “sentinel of the genome” to repair DNA injury
in a timely manner. Of note, DNA is wrapped in around histones forming the
nucleosome, the fundamental unit of chromatin (187, 188). The nucleosome is
further compacted into higher order chromatin structure with linker histone protein as
well as non-histone proteins (189, 190). Although this higher order chromatin
structure appears to be functioning as a barrier to DNA-associated processes such
as replication, transcription as well as DNA repair; the highly dynamic chromatin
structure is modulated by various ways such as DNA methylation (191), posttranslational modifications of histones and non-histone proteins (10, 192),
nucleosome/chromatin remodeling complexes (193). Among these different factors,
post-translational modification of chromatin that can be dynamically added or
removed by enzymatic reactions has emerged as a key regulatory player in
modulating nucleosome in response to DNA damage. While phosphorylation,
ubiquitination, acetylation, methylation, ubiquitination, SUMOylation and ADP-
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ribosylation are among the best-studied modifications, recent studies indicate the
existence of additional PTMS such as crotonylation, succinylation, and malonylation
of histone and non-histone proteins (194). In addition to altering nucleosome
dynamics, these above-mentioned PTMs recruit reader proteins that further
modulate chromatin remodeling during events such as DNA repair and transcription.
Although each of this modification entails a distinct set of enzymes that catalyze and
disassemble chromatin PTMs, recent studies from different groups indicate that
potential cross talks exist among different post-translational modifications that
function in a coordinated fashion at the damaged chromatin to execute efficient DDR
signaling. One classic example of this potential cross talk is γH2A.X and MDC1
phosphorylation-dependent H2A/H2A.X ubiquitination by the RNF8/RNF168-Ubc13
enzymatic machinery at the DNA double-strand break sites that function
synergistically to activate the DDR signal and facilitates downstream DDR factors
recruitment such as 53BP1 and components of the BRCA1-A complex (37-39, 41,
43-45). While this represents only a small fraction of crosstalk at the damaged
chromatin, emerging evidence support a more complex picture of the crosstalk
among different PTMs to induce efficient DSB response. This potential crosstalk not
only transduce the damage signal, but also regulates recruitment of effector proteins
at damage sites, transcriptional silencing as well as coordination with DNA
replication (16, 195, 196), emphasizing the functional significance of different posttranslational modifications at damaged chromatin.
In this study, I investigated the role of phosphorylation and ubiquitination, two
of the most well studied post-translational modifications at damaged chromatin. The
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novel findings obtained from this study highlight the significance of cross talk among
phosphorylation and ubiquitination at DSB sites. In addition to γH2A.X and MDC1
phosphorylation and Lys63-linked ubiquitination-dependent BRCA1 localization at
DBSs, I showed that DNA damage-induced Abraxas phosphorylation at the S404
site is crucial for efficient BRCA1 dimerization and efficient accumulation to damage
sites to initiate DNA repair (87). Also, I showed that along with Lys63-linked
ubiquitination, damage chromatin is modified with Lys11-linked ubiquitination in
phosphorylation-dependent manner to induce transcriptional silencing at the vicinity
of the DSB sites. These findings not only deepen our understanding of
spatiotemporal regulation of DDR factors at the damage sites but also provide
mechanistic insights into how damaged chromatin is orchestrated in response to
DNA damage to inhibit transcription. While these studies reveal a regulatory role of
post-translational modifications at the damage sites, they also open up new areas of
research to understand the role PTMs in regulating the DDR pathway. Future
studies aiming to understand PTMs in the DDR will likely identify novel molecules in
the DNA damage response pathway and will provide potential therapeutic
opportunities to diseases associated with defective DDR signaling.
4.2 Final words
The DNA damage response is absolutely essential for maintaining the
genomic stability and defective DDR signaling has been characterized as one of the
hallmarks of cancer (7) and has been attributed to many different types of cancer
(197). While defects in the DDR signaling has been the major factor in tumorigenesis
as well as other diseases, this provides a unique opportunity to exploit the DDR
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system as a potential therapy of cancer with radiotherapy and chemotherapy
regimens. This is best exemplified by the synthetic lethality approach with the
PARP1 inhibitor to induce cell death in tumor cells defective in BRCA1 or BRCA2
genes. Olaparib, the PARP1 inhibitor, has recently been approved by the FDA for
treatment of women with ovarian cancer. Recent analysis indicate that there are at
least 450 genes integral to the DDR and choice of drug target depends on the type
of DNA damage repair to be inhibited given multiple repair mechanisms exist in cells
to repair damaged DNA. While many of the compounds for DDR targets are already
approved or under clinical trials, a large number are still in the discovery phase,
potentially representing next generation DDR targets (198). Interestingly, among
different PTMs involved in the DDR pathway, phosphorylation and ubiquitin-modified
proteome and corresponding enzymatic machinery have emerged as a highly
druggable class of proteins that include protein kinases such as ATM, ATR, DNAPK, Chk1, as well as many of the E3 ubiquitin ligases (24 total) involved in various
DDR pathways (198). The promising results from these studies emphasize how
post-translational modifications such as phosphorylation and ubiquitination and
crosstalk among these PTMs in the DDR signaling can potentially be harnessed as a
viable therapeutic approach in cancer cells. Therefore, detail understanding of PTMs
in the DDR pathway will likely to identify new molecules in the near future that can
be targeted for cancer therapy. In this light, my study provides crucial mechanistic
insights into the DDR pathway. Although there remain questions that require further
investigation, findings from this study will broaden our understanding of the
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complexity of the DDR signaling as well as expand the list of DDR factors in DSB
repair pathway.
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